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We set out to test the hypothesis that the gastrointestinal tract (GIT) of ruminant
animals catabolizes amino acids (AAs) preferentially. We sought to determine
whether this catabolism represents an obligate requirement, and whether this
requirement stems from the need to generate energy or support other metabolic
demands. The aim was to determine the composition of macronutrients (AAs, short
chain fatty acids, and glucose) utilized by the GIT, and the influence of general and
specific nutrient supplies on their routes of metabolism. Increasing protein supply to
the small intestine did not alter the total amount of glucose removed by the GIT
indicating, that glucose removal and therefore utilization is obligatory. In contrast, the
net removal of AAs occurred at a constant proportion of arterial and luminal supplies.
This translated to larger amounts of AAs removed from blood circulation, and from
the lumen of the small intestine in response to increased small intestinal and blood
supplies. In this respect, the net absorption of branched chain AAs was, unlike other
essential AAs lower than 100%. Further, glutamate and glutamine net appearance
across the whole GIT and small intestine was unaffected by protein supply. The
disproportionate utilization of BCAA, glutamate, and glutamine as compared to other
AAs suggested that their metabolism occurred toward specific metabolic
requirements, possibly energy production. When Krebs cycle metabolism was
investigated using individual AAs, glucose, and short chain fatty acids, leucine and
valine did not contribute to the flux of Krebs cycle intermediates. Conversely, α-
ketoglutarate flux originated mainly from glutamate, and to a lesser extent from
glutamine. Though glucose was metabolized to pyruvate and lactate, glucose did not
contribute to Krebs cycle intermediates. Overall, these results indicated that glutamate
plays an important role in energy metabolism, and in insuring replenishment of Krebs
cycle intermediates that leave the cycle via cataplerosis. Yet, the results raised new
questions that ought to be addressed in future studies. The fate of glutamine carbon,
the metabolic significance of leucine and valine deamination, and the role of glucose
partial catabolism to lactate need to be investigated.
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INTRODUCTION
Ruminants are by far the most efficient farm animals in converting plant products
that are inedible by humans into high quality food products such as meat and milk.
However, the metabolic adaptation of ruminants to using low quality feed ingredients is
coupled with a low efficiency of depositing amino acids (AAs) and energy into body
tissues and milk proteins.
Gaps in our knowledge exist in relation to absorptive and post-absorptive nutrient
metabolism. One area that deserves further examination is how nutrients are partitioned
between catabolism and anabolism. A better understanding of these control mechanisms
may provide new avenues for enhancing the efficiency of AA utilization by ruminants
through formulation of diets better suited to matching the metabolic capabilities of
ruminants. Furthermore such information will also be valuable in the development of
predictive models of nutrient absorption and utilization in farm animals. The overarching
goal is to maximize production efficiency and to decrease the impact of animal
production systems and their wastes on the environment.
One aspect of the poor efficiency of nutrient utilization by ruminants relates to the
high metabolic demands for AAs and energy substrates by the gastrointestinal tract (GIT)
and the liver. These tissues are the most metabolically active tissues in the body, and
therefore targeted investigations of these tissues may provide opportunities for decreasing
these losses in nutrient utilization. The research conducted in this dissertation had the aim
of determining the composition of macronutrients (AAs, short chain fatty acids and
glucose) utilized by the GIT and the influence of general and specific nutrient supplies on
their routes of metabolism.
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The GIT has received a lot of attention not only for the role it plays in nutrient
digestion and absorption, but also for its high anabolic and catabolic activity which
impacts upon nutrient availability to productive tissues (e.g. muscle, mammary gland,
conceptus). What is remarkable is that the small size of the GIT is coupled with a high
rate of O2 consumption and protein synthesis. In sheep for example, the GIT represents
less than 10% of empty body weight (McLeod and Baldwin, 2000) yet its metabolic
activity accounts for 30% of whole body oxygen consumption (Burrin et al., 1989) and
25 to 35% of whole body protein synthesis (Lobley et al., 1994). While part of the high
metabolic demand for AAs by the ruminant GIT relates to the net losses of tissue and
secretory proteins (Burrin et al., 1989; Neutze et al., 1997), evidence in monogastric
species also indicates that AA make major contributions as substrates for energy
generating pathways. In ruminants, while it would be expected that AAs make similarly
large contributions to energy metabolism by the GIT, there is a paucity of information to
support this role. Therefore, the extent that AA and other substrates contribute to
catabolic pathways of energy generation will be a focus of this thesis.
The overall hypothesis of this thesis research is that the GIT of ruminant animals
catabolizes AA preferentially. In this respect it was important to determine whether this
catabolism represents an obligate requirement and whether this requirement represents
the need to generate energy or support other metabolic demands.
The objectives of this project are to: 1) Determine whether changes in small
intestinal protein supply alters glucose metabolism by the portal (PDV) drained viscera.
2) Determine the patterns of AA net metabolized by the mesenteric (MDV) and PDV and
whether this pattern of use remains constant when intestinal protein supply is increased,
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3) Determine whether the changes in small intestinal protein supply alters the extent that
AA are utilized from luminal (first-pass) versus systemic (second-pass) sources. A related
objective was to determine whether changes in AA use by the GIT were inversely related
to GIT metabolism of glucose, and 4) Determine the contributions of individual amino
acids, glucose, and short chain fatty acids (SCFA) to Krebs cycle metabolism by rumen





The gastrointestinal tract (GIT) of animals is considered to be a major site of AA
catabolism and use for protein synthesis. Studies conducted in monogastric (pigs,
humans, mice, rats) and ruminant (sheep, beef and dairy cattle) species have shown that
the removal of AA by the GIT, both essential and non-essential, occurs at rates that are
not proportional to its size. This high AA requirement relates to the high rates of protein
synthesis and turnover (25 to 100% per day; Lobley et al., 1994) by the GIT tissues.
Furthermore, energy utilization by the GIT is also high and may be related to the high
rate of protein synthesis. What is unique about the GIT is that most nutrients are deliver
to and extracted from the luminal aspect during absorption and from the arterial blood
supply. This feature means that the GIT is capable of dictating the initial supply of
nutrients to post-absorptive tissues, and that the GIT has the potential to act as a
competitor with productive tissues (e.g. muscle, mammary gland) for AAs and energy
substrates.
There has been some evidence in the literature that the GIT may be flexible in
substrate selection for catabolism. Understanding the roles AAs serve as substrates for
energy production and how their utilization is influenced by the supplies of
macronutrients (i.e. protein, carbohydrates and volatile fatty acids) may provide clues to
feeding strategies that reduce AA use by the GIT. This in turn would provide larger
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amounts of AAs to the liver and beyond to productive tissues for tissue protein gain, and
also improve the efficiency of AA utilization.
Gastrointestinal tract removal
Tissue removal of AAs can be estimated in vivo by measurement of the product of
arterio-venous concentration difference and blood flow, which in the case of the ruminant
GIT most often involves blood collected from the portal vein. When portal blood is
collected, net nutrient flux values represent the removal or absorption by the whole GIT,
i.e. the portal drained viscera (PDV) including the rumen, small intestines, hind gut and
the pancreas. With collection of mesenteric drained visceral (MDV) blood flow, small
intestinal removal or absorption can also be estimated. Based on PDV measurements,
some AAs have been found to be net produced by the GIT, for example alanine and
arginine. By contrast, PDV net fluxes of glutamine and glutamate are low and often
negative, reflecting their net metabolism by the PDV (Burrin et al., 1991; Berthiaume et
al., 2001; Rémond et al., 2003). For most essential AA, their net appearance across the
MDV most often equals the amounts disappearing from the lumen of the small intestines.
The latter reflecting net tissue protein balance of those tissues, i.e. the GIT is neither
gaining nor losing net protein.
In fed sheep, PDV appearance of many AAs does not account for all the AAs
disappearing from the small intestines (Tagari and Bergman, 1978). In that study,
glutamine was found to be removed the most at two levels of protein intake, whereas
portal appearance of glutamate increased and that of aspartate decreased in response to
increased protein feeding. Others have measured PDV net flux of AAs across a wide
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range of feeding conditions. In some reports, intestinal supplies of glutamate and
glutamine were completely removed by the PDV in sheep and cattle, and the amounts
removed were not affected by level of feed intake (Huntington and Prior, 1985; Nozière
et a., 2000), protein supply (Bruckental et al., 1997) or by fasting (Heitmann and
Bergman, 1980). However, in other studies (Burrin et al., 1991; Berthiaume et al., 2001;
Rémond et al., 2003), only glutamine was completely removed by the PDV, whereas
glutamate was net absorbed by the PDV. Glutamate absorption is also responsive to level
of nutrition, with net absorption greater in lambs fed ad libitum compared to those fed at
maintenance (Burrin et al., 1991). Most of these data in ruminants represent fluxes across
the PDV. In studies where MDV net flux has been measured in ruminants, glutamine and
glutamate were also found to be net absorbed from small intestine (Berthiaume et al.,
2001; Rémond et al., 2003). Therefore, the removal of glutamate and glutamine by the
PDV can be attributed to arterial use by the rumen and hind gut tissues, in addition to that
removed from the small intestinal lumen
All EAA are net absorbed by PDV of well fed ruminants (Tagari and Bergman,
1978; Burrin et al., 1991; Nozière et al., 2000; Berthiaume et al., 2001), but to varying
extents. Net removal of EAA by the PDV was negative only when ruminants were fed to
0.5 times maintenance energy and protein requirements (Nozière et al., 2000), indicating
that the PDV net removed EAA from the systemic circulation and from the lumen of the
small intestines. In sheep fed to maintenance (Burrin et al., 1991) or subjected to short
term fasting (Heitmann and Bergman, 1980) EAA are net absorbed into the portal vein.
Despite the appearance of AA in the portal drainage, PDV removal occurs at rates
that are higher than for the MDV (MacRae et al., 1997; Lobley et al., 2003). The
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difference in EAA net absorption is due to the removal of those AA from the circulation
by the forestomach and hind gut (Rémond et al., 2000; Rémond et al., 2003). The GIT of
sheep fed a forage diet removes 0.17 to 0.39 of EAA infused into the small intestines
while systemic removal was 0.06 to 0.13 of arterial supply (MacRae et al., 1997). In that
study, the arterial supply of EAA, except for phenylalanine and histidine, provided 0.75
to 0.82 of the EAA sequestered by the GIT. In this connection, systemic AA removal by
the GIT correlates well with fluctuations in arterial AA concentration (Lobley et al.,
2001). These findings highlight the importance of the blood circulation in the provision
of AAs to the GIT.
Protein synthesis
In sheep, protein synthesis in MDV and PDV account for 0.20 and 0.35 of whole
body protein synthesis rate (Neutze et al., 1997; Lobley et al., 1994). Furthermore,
protein turnover in the small intestines occurs at a greater rate in the mucosa than in the
serosa (0.64 and 0.42/d; Lobley et al., 1994).
At a minimum, AA utilization by the GIT should reflect their requirements for
synthesis of mucins, enzyme secretions and GIT tissue proteins. In this respect, the
proportional removal of EAA from luminal and arterial supplies by the GIT of ruminants
correlates well with their profile in whole GIT tissue proteins (MacRae et al., 1997).
Despite the high rates of protein synthesis by GIT tissues, protein retention does
not exceed 0.03 of whole body protein gain (MacRae et al., 1993). This is due in part to
the losses attributed to the incomplete reabsorption of intestinal secretion. For example,
the reabsorption of small intestinal mucin, which is rich in threonine and valine (Mukkur
et al., 1985), does not exceed 0.75 at the ileum (van Bruchem et al., 1997).
8
Protein synthesis is also energetically demanding. In cattle, up to 0.30 of heat
production has been attributed to protein synthesis (Lobley et al., 1980). Consequently,
protein synthesis places a high demand on energy substrates including AAs.
Catabolism
The high rate of AA utilization by the GIT, in particular the NEAA, occurs at
rates that exceed their requirements for protein synthesis alone (Reeds et al., 2000). The
mismatch between tissue composition and AA utilization by the GIT reflects the
metabolism of some AA in pathways other than protein synthesis, for example NEAA
synthesis (Wu, 1998), or in catabolic routes for energy production (Reeds et al., 2000).
The metabolic pathways of all twenty amino acids converge to five end-products, all of
which may enter the Krebs cycle (Figure 1.1). As a result, the carbon skeleton of AA can
be diverted towards gluconeogenic (alanine, lactate) or ketogenic end-products
(acetoacetate), completely oxidized to CO2, or their carbon skeletons can be used for
NEAA and lipid biosynthesis.
Non-essential amino acids. Glutamine has been singled out as the main
respiratory substrate for the rat small intestines (Windmuller and Spaeth, 1974, 1978,
1980). In those studies more than half of glutamine carbon appeared as CO2, which
accounted for one-third of total CO2 production by the small intestines. However,
uncertainty has since emerged with respect to the fates of glutamine carbon and nitrogen
and whether glutamine oxidation in the GIT represents a requirement or occurs as a
passive response to supply and concentration.
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Figure 1.1. Points of entry of amino acids to the citric acid cycle. Some amino acids have




































Firstly, glutamine oxidation is believed to occur through a pathway that involves
the intermediary catabolism to glutamate and thence to α-ketoglutarate (Windmuller and
Spaeth, 1974). However, studies conducted using [1-14C], [5-14C] or [U-14C]glutamine
tracers in rats have shown that glutamine oxidation is incomplete and that this catabolism
could involve pathways other than the Krebs cycle (Watford, 1994). It was suggested that
the appearance of labeled CO2 from glutamine provided unequivocal evidence of
glutamine decarboxylation, which is similar to previous observations (Windmuller and
Spaeth, 1974). However, the lack of labeling in α-ketoglutarate, malate, citrate, and
fumarate ruled out the Krebs cycle as a possible pathway for glutamine oxidation
(Watford, 1994).
Glutamine-N is important in purine and pyrimidine synthesis (Gate et al., 1999).
In rapidly dividing cells of the small intestine, which are replaced every 1-4 d in
ruminants (Attaix and Meslin, 1991), nucleotide biosynthesis may be the most important
process driving glutamine utilization, not energy production as previously thought
(Newsholme et al., 1985). The utilization of glutamine nitrogen for purine and pyrimidine
biosynthesis does not reflect a large quantitative requirement for glutamine because only
5% of glutamine amido-N is recovered in RNA and DNA extracted from GIT tissues
(Gate et al., 1999). However, it has been suggested that the high rate of glutaminolysis in
many tissues is required in order to maintain a small, yet metabolically flexible, nucleic
acid precursor pool for immediate repair responses to damage (Newsholme et al., 1985).
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Second, studies have shown that in pig small intestine glutamate and glucose
contribute more to oxidative energy generation than does glutamine (Stoll et al., 1999).
Therefore glutamine catabolism through deamidation may reflect a requirement for
glutamate, and not for glutamine per se (Reeds and Burrin, 2001). In fact, glutamate
addition to isolated sheep enterocytes decreased glutamine oxidation (Oba et al., 2004).
Equally important is the fact that other NEAAs, namely glutamate and proline, could
substitute for glutamine in non-protein synthetic metabolic pathways involving arginine
and citrulline synthesis (Wu, 1996; Brunton et al., 1999).
TABLE 1-1.
Pathways supported by glutamine metabolism in small intestinal mucosa1







1 Reeds and Burrin 1991.
Lastly, glutamine removal by the GIT of ruminants exceeds that of other AA, yet
oxidation occurs at rates lower than those observed in the simple stomached animals.
Only 9 to 25% of glutamine carbon appeared as CO2 with dairy cow enterocytes (Okine
et al., 1995) as compared to 55-70% with rat and piglet enterocytes (Windmuller and
Spaeth, 1974; Stoll et al., 1999). In addition, glucose provision to sheep enterocytes
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reduced glutamine oxidation but had no effect on CO2 production from glutamate (Oba et
al., 2004). It is important to note that the results in ruminants are from animals at
different physiological conditions (lactating cows vs growing sheep) and substrate
concentrations in the incubation media (1.0-6 mmol/L).
Enteral glutamate has been shown to be extensively removed on first pass in pigs,
and glutamate catabolism accounted for 0.10-0.36 of total CO2 production by the PDV
(Stoll et al., 1999; van der Schoor et al., 2001) compared to 0.19 for glutamine (Stoll et
al., 1999). These observations support the suggestion that glutamate is a more important
substrate for catabolism than is glutamine (Reeds and Burrin, 2001). A further
observation that supports this view is that in sheep enterocytes glucose addition did not
reduce glutamate oxidation to CO2 (Oba et al., 2004), and therefore glutamate catabolism
may represent a requirement.
In rats, small intestinal catabolism to CO2 of aspartate (0.51) and arginine (0.14)
is also significant (Windmueller and Spaeth, 1975; 1976). Also, the synthesis of other
metabolic end-products (lactate) and AAs (alanine, proline, citrulline and ornithine) from
glutamine, glutamate, aspartate and arginine is significant. In fact, the portal appearance
of alanine, in all species studied, far exceeds intake or intestinal disappearance (Stoll et
al., 1998; Stoll et al., 1999).
Essential amino acids. Many of the studies carried out that have examined EAA
oxidation by the ruminant GIT have used leucine tracers (Pell et al., 1986; MacRae et al.,
1997; Capelli et al., 1997; Yu et al., 2000). In sheep fed lucerne pellets, leucine oxidation
accounted for 0.17 of arterial leucine sequestered by the GIT (MacRae et al., 1997).
Changes in leucine catabolism have been shown to occur as a result of infection with
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intestinal parasites. Here, leucine oxidation increased from 0.12 to 0.21 of leucine
sequestered by the GIT of sheep challenged with parasitic nematodes (Yu et al., 2000). In
this study, the increase in leucine oxidation correlated with an increase in GIT protein
turnover with no change in the fractional rate of leucine oxidation. Diet alterations have
also been shown to affect EAA oxidation by the dairy cow GIT. Increasing the supply of
metabolizable protein to dairy cows increased leucine oxidation from 0.16 to 0.22 of
small intestinal utilization (Lapierre et al., 2002).
Very low rates of luminal leucine oxidation have been reported for sheep (0 to
0.05) as compared to the extent of arterial leucine oxidation (Capelli et al., 1997; MacRae
et al., 1997b; Yu et al., 2000). These observations are in agreement with the observation
that 0.80 EAA sequestered by the GIT, including leucine, occurs from the systemic
supply (MacRae et al., 1997b).
In the most comprehensive study to date in ruminants, 13C-tracers of leucine,
methionine, lysine and phenylalanine were infused via the jugular vein into sheep, and
13CO2 release by the PDV monitored (Lobley et al., 2003). Here, there was detectable
oxidation of only leucine and methionine, amounting to 8% and 3%, respectively, of their
sequestration from the arterial blood supply to the PDV (Lobley et al., 2003). In that
study, no significant oxidation of lysine and phenylalanine was detected. A proviso in
that study was that the tracers were administered into the blood circulation only, and so
oxidation of the AAs represented that by the arterial facing aspect of the GIT tissues, not
the intestinal lumen aspect. In a series of studies in pigs, however, where the 13C tracers
were given via the feed and infused into the blood supply, oxidation of many of these AA
was observed (Stoll et al., 1999; van der Schoor et al., 2001; van Goudoever et al., 2001).
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In one of these studies, leucine oxidation by the PDV of piglets fed a diet
adequate in protein accounted for 0.18 of total CO2 production by PDV with duodenal
leucine (0.12) contributing more to total oxidation than leucine from the systemic
circulation (0.06, van der Schoor et al., 2001). In a companion study by this group, lysine
was also demonstrated to be oxidized by the GIT of pigs, with lysine oxidation by the
PDV accounted for 0.31 of whole body lysine oxidation (van Goudoever et al., 2001).
However, unlike leucine, which was oxidized from both the arterial and luminal supplies
to the GIT, only dietary (luminal) lysine was oxidized.
Threonine is also catabolized by the PDV of pigs, however, most of the enzyme
activity for threonine catabolism (threonine dehydrogenase) is localized to the liver and
pancreas (Le Floc’h et al., 1997). Therefore, glycine production from threonine in the
pancreas is the major contributor to threonine catabolism by the PDV (Le Floc’h and
Sève, 2005). Others have reported no catabolism of threonine to glycine by the GIT as
indicated by the lack of labeled 13C incorporated into glycine released by the GIT
(Schaart et al., 2005). These authors did report 13CO2 production by the PDV, but only
when labeled threonine was derived from the arterial blood. Consequently, threonine
oxidation by the PDV accounted for 0.13 to 0.50 of whole body threonine oxidation.
Metabolic plasticity and AA catabolism
Cells lining the GIT of rodents (Fleming et al., 1997) and ruminants (cattle:
Harmon, 1986; Okine et al., 1995; sheep: Oba et al., 2005) exhibit metabolic plasticity in
substrate selection for catabolism. There are, however, notable differences between
species with respect to the major substrates metabolized.
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In rat small intestinal mucosa, glucose addition to the incubation media did not
alter catabolism of glutamine to CO2 (Watford, 1994; Fleming et al., 1997), whereas
glutamine addition reduced CO2 production from glucose (Fleming et al., 1997). By
contrast, in ruminants, glutamine oxidation was reduced when the concentration of other
substrates was increased. Here, glutamine oxidation by isolated rumen epithelial cells
from steers was decreased in the presence of glucose and butyrate (Harmon et al., 1986).
In similar studies conducted with sheep and dairy cow enterocytes, glucose addition
decreased glutamine oxidation (Oba et al., 2004; Okine et al., 1995). Despite the decrease
in glutamine oxidation in response to glucose addition, glutamate oxidation was not
affected (Oba et al., 2004).
In rat enterocytes, glutamine carbon does not appear in the Krebs cycle
intermediates despite the production of labeled CO2 from the glutamine radio-tracer
(Watford, 1994). The authors suggested that glutamine undergoes partial catabolism to
lactate and alanine. In the sheep GIT tissues, glutamine is used primarily for protein and
nucleotide synthesis (Gate et al., 1999). Because purine and pyrimidine synthesis occurs
in the cytosolic compartment, partial catabolism of glutamine may also generate lactate
and alanine.
Postabsorptive amino acid utilization
The ability to decrease AA catabolism by the GIT should, in turn, lead to an
increase in portal AA absorption and consequently provide greater supplies of AAs to the
liver and beyond to productive tissues for milk casein and muscle protein production.
The selective removal of AAs by the GIT tissues has the potential to create an
imbalance in the pattern and quantity of AAs available to productive tissues (e.g. muscle,
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mammary gland, and uterus) for anabolic use. One consequence of reducing GIT tract
utilization of AA is their increased supply to the liver. In a study employing pregnant,
non-lactating dairy cows, AA removal by the liver exceeded the requirements for urea
synthesis, and therefore it was suggested that AA utilization supports primarily hepatic
protein synthesis (Wray-Cahen et al., 1997). The pattern of free AAs available to non-
splanchnic tissues is altered relative to that which is absorbed from the GIT as a result of
hepatic removal of AAs from the portal circulation (Wray-Cahen et al., 1997; Lobley et
al., 2001; Raggio et al., 2004). Despite the hepatic removal of AAs, when mesenteric
supply of AA is increased by infusion the arterial blood concentration for most AAs is
increased.
Due to the low extraction of BCAA and lysine by the liver of ruminants (Lobley
et al., 2001; Raggio et al., 2004), larger amounts of these AAs appeared in the peripheral
circulation in response to increments of metabolizable protein (Raggio et al., 2004). This
resulted in an increased removal by the mammary gland and translated into a significant
increase in milk output and milk protein yield. Feed intake has also been shown to
increase arterial AA concentration. The arterial AA concentrations of sheep fed
increasing levels of a dried grass diet (0.5 to 2.5 × maintenance energy) were elevate with
each increment, and, consequently, this lead to an increase net removal of several AA by
hind leg tissues (Hoskin et al., 2001; Hoskin et al., 2003; Savary-Auzeloux et al., 2003).
This response likely resulted in a net muscle protein gain, as several of these AA
(phenylalanine, tyrosine, and serine) cannot be catabolized by the leg tissues.
To date there are several questions about AA metabolism by the GIT of ruminants
that remain unanswered. These questions include:
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1. Are AA catabolized by the GIT as part of a fixed metabolic requirement?
2. If AA catabolism is not fixed how would changing dietary conditions,
such as feeding carbohydrates or forages affect it?
3. Does AA oxidation represent a complete or partial catabolism? To what
metabolic intermediates AA contribute to?
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Glucose
Ruminants have evolved to survive on and utilize plant materials that are high in
carbohydrates, mainly cellulose, hemicellulose, pectins, fructans and starches. In forage-
based diets, very little starch escapes rumen microbial fermentation and so the small
intestines ‘sees’ negligible carbohydrate monomer for digestion and absorption (Janes et
al., 1985). In addition to rumen escape starch, some glucose is absorbed from the small
intestine that arises from digestion of microbial polysaccharides (MacRae and Armstrong
1966; McAllan and Smith, 1974) and from intestinal muco-polysaccharides (mucins;
Mukkur et al., 1985). Despite the low dietary supplies, glucose turnover rate in ruminants
is only slightly lower than in non-ruminants on a body weight basis (Annison and White,
1961; Leng et al., 1967). The latter reflects ruminants’ reliance on gluconeogenesis to
meet their requirements for glucose in the starved and fed states.
In modern intensive animal production cereal grains that are rich in starch 58-
77%; Huntington, 1997) have been widely used as a means to increase production
performance in beef finishing and dairy operations. The additional benefit of
supplementing forage based diets with grains to ruminants relates to changes in the
pattern of short chain fatty acid production in the rumen and the “leakage” of starch to the
small intestine.
Grain supplementation increases the proportion of propionate produced in the
rumen as compared to other short chain fatty acids (Bergman, 1990). The increase in
propionate production increases the availability of this short chain fatty acid for hepatic
gluconeogenesis (Leng et al., 1967). Another reason for the improved performance is that
dietary starch reaching the small intestines undergoes digestion by pancreatic and
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intestinal enzymes, resulting in glucose available for absorption (Janes et al., 1985). In
either case, the overall result is an increased glucose supply to the gastrointestinal tract
and beyond to other tissues.
The gastrointestinal tract expresses the full compliment of glycolytic enzymes.
What remains less certain is the metabolic need for glucose metabolism by the GIT. That
is, does glucose metabolism occur to provide energy via the Krebs cycle or is glucose
incompletely metabolized for other purposes?
Glucose luminal supply is mainly the proportion of dietary starch that escapes
rumen fermentation and reaches the small intestine where it is digested and could
represent about 0.25 of starch intake (Owens et al., 1986; Kreikemeier et al., 1991;
Huntington, 1997). Arterial supply on the other hand is glucose that is absorbed from the
small intestine in addition to glucose from gluconeogenesis. Glucose absorption from the
lumen of the small intestine represents a smaller supply relative to that from the arterial
blood (Janes et al., 1985). For example, in sheep fed a maize diet glucose luminal supply
(i.e. glucose absorption) was 23 mmol/h whereas for the same animals arterial supply was
333 mmol/ h.
The ability of ruminants to efficiently digest starch in the small intestine and their
ability to absorb glucose has been a subject of many reports. Some have suggested that
digestion in the small intestines is the limiting process in starch utilization (Huntington,
1997) whereas others have proposed that the rate of glucose absorption (transport) places
the greater limitation on its availability (Kreikemeier et al., 1991; Kreikemeier and
Harmon, 1995; Harmon and McLeod, 2001).
20
Intestinal starch digestion and absorption
Shifting the site of starch digestion from the rumen to the intestine has been
suggested to be more energetically beneficial to ruminants. This is based on theoretical
grounds that more energy from glucose (starch) is lost as heat during rumen fermentation
than energetic losses during tissue metabolism of glucose (Owens et al., 1986; Harmon
and McLeod, 2001). It is estimated that 0.18-0.42 of dietary starch may escape rumen
fermentation (Owens et al., 1986) this provides sheep (95g/d; Janes et al., 1985), beef
(500 g/d; gSindt et al., 2006), and dairy cows (1-3 kg/d: Knowlton et al., 1994; Rémond
et al., 2004) small intestine with large amounts of starch.
Digestion. In ruminants, starch is digested in the small intestine as it is in
monogastric animals through a series of enzymatic hydrolysis steps. Pancreatic α-
amylase secreted in the duodenum is the first enzyme acting upon starch molecules,
hydrolyzing amylose and amylopectin at α-(1, 4) glycosidic linkages to maltose and
dextrin moieties. Maltose comprises two glucose molecules linked by α-(1, 4) linkages
whereas dextrins are glucose molecules linked at α-(1, 6) branch points. Following α-
amylase hydrolysis, maltose and dextrins are further hydrolyzed before entering intestinal
cells. Maltose and dextrins are hydrolyzed to glucose by brush border membrane α-
glycosidases, mainly maltase and isomaltase in ruminants (Harmon 1992; Harmon 1993
Bauer; 1995).
Various reports seem to agree that ruminants have a limited ability to digest starch
entering the small intestine (Huntington, 1997) and that this ability decreases with
increasing intake (Kreikemeier et al., 1991). Pancreatic α-amylase activity and secretions
have been shown to decrease with increasing postruminal starch supply (Walker and
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Harmon. 1995). This decrease in α-amylase activity and secretion may explain the
reduced efficiency with post-ruminal starch supply. Reports indicate that this decrease
could be prevented by increasing AA supply post-ruminally. In beef cattle, casein
infusion has been shown to increase α-amylase activity in the small intestine (Swanson et
al., 2002; Richards et al., 2003). It was suggested that postruminal AA supply counteracts
the negative response of starch through changes in mRNA expression (Swanson et al.,
2003) possibly mediated through insulin. In contrast, others have suggested that the
reduced efficiency of starch utilization with in the small intestines relates to limitations in
glucose transport and absorption (Ørskov et al., 1971; Shirazi-Beechey et al., 1991).
Absorption. Glucose transport into intestinal cells is another factor that could
influence glucose appearance in the blood. Glucose is transported (Figure 1.2) by two
processes, paracellular diffusion and sodium-glucose transporter (SGLT1), the former
being only a minor route (<10%) of total glucose absorption (Shirazi-Beechey et al.,
1996; Harmon and McLeod, 2001). The highest SGLT1 transporter activity has been
observed in pre-ruminants which declined to negligible levels in ruminant lambs (Shirazi-
Beechey et al., 1991). However, the decline in glucose transporter activity in ruminant
sheep has been shown to be reversible by infusion of glucose into the small intestines
(Shirazi-Beechey et al., 1991). This adaptation to increased glucose supply to the small
intestines was first reported in sheep infused with increments (20g/d) of glucose (Ørskov
et al., 1971). In that study, sheep were able to cope with glucose loads up to 300 g/d, and
this amount was considered the maximum without causing post-ileal spillage. Later, it
was reported that part of the adaptive response to increased glucose availability in the
small intestines was related to a 40-80 fold increase in SGLT1 transporter activity
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(Shirazi-Beechey et al., 1991). Furthermore, the SGLT1 response has been linked to a
glucose sensing mechanism in the small intestines (Harmon and Mcleod, 2001).
In vivo studies relevant to starch digestion and glucose absorption from the lumen
of the small intestine provide a wealth of information. However such results should be
interpreted with caution and interpreted in relation to the experimental conditions
imposed. For example, short term infusions of starch and/or glucose (Kreikemeier et al.,
1991) have provided estimates of the upper limits to digestive and absorptive capacities
of ruminants relative to their particular physiological and dietary status. Further, such
short term infusion regimes will not reflect the long-term adaptative mechanisms that
ultimately will determine the practicality of supplying greater amounts of starch to
ruminants (Janes et al., 1985; Shirazi-Beechey et al., 1991).
Despite the controversy surrounding starch utilization in ruminants it is clear that
the GIT remains, despite it’s relatively small size, a major site of extensive glucose
metabolism from the arterial blood (Balcells et al., 1995; Cappelli et al., 1997) and
luminal supplies (Cappelli et al., 1997; Seal and Parker, 1994; van der Schoor et al.,
2001; Stoll et al., 1999).
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In ruminants, nutrients are supplied to the gastrointestinal tract mainly from the
arterial blood supply, especially for the rumen and the hindgut tissues which have
limited, if any, capacity to absorbed glucose and amino acids from their luminal aspects
(Rémond et al., 2000). In situations such as feeding high grain diets the proportion of
glucose that is unaccounted for in the portal blood is assumed to have been utilized
during absorption.
The contribution of absorbed glucose to body requirements could vary depending
on diet. Absorbed glucose represents 10% of whole body requirements when ruminant
are fed high forage diets, but 60% when high levels of concentrates are fed (Bergman,
1973; van der Walt et al., 1983; Janes et al., 1985). This limited contribution of absorbed
glucose to whole body requirements reflects in part its metabolism (0.25-0.35 of whole
body irreversible loss) by the GIT tissues (Huntington et al., 1980, Huntington, 1982;
Balcells et al., 1995; Cappelli et al., 1997).
Glucose serves a variety of metabolic functions (Figure 1.3) including precursors
for nucleotide synthesis and intermediary metabolites, lactate and alanine, and energy
production. Several studies have reported that epithelial and mucosal tissues have the
ability to oxidize glucose for energy production both in monogastric (Windmueller 1974;
Stoll et al., 1998) and ruminant species (Okine et al., 1995; Seal and Parker, 1996; Oba et
al., 2004; Harmon, 1986; Baldwin and McLeod 2000). In ruminants, glucose catabolism
by enterocytes depends upon the presence of other metabolites such as glutamine (Okine
et al., 1995) or propionate (Harmon, 1986; Oba et al., 2004). Knowing the fuels selected
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for energy generation and the flexibility of the GIT to utilize an array of substrates has
implications on the prediction of nutrients to peripheral tissues for anabolism.
In this respect the response of the GIT to glucose supply has been inconsistent,
while in some studies, glucose infusion into the jugular vein (Balcells et al., 1995) or the
abomasum (Harmon et al., 2000) decreased AA acid absorption by the PDV. Others
however, reported an increase in total NEAA absorption in response to intrajugular and
intraduodenal glucose. It could be suggested that glucose would spare AAs from
catabolism, therefore increased their appearance in PDV. This however, is based on the
grounds that glucose and AAs share the same catabolic pathways.
Oxidation
Glucose contributes carbon to two oxidative pathways: the Krebs cycle and the
oxidative arm of the pentose phosphate pathway. In the Krebs cycle oxidation is
considered complete only if glucose enters at acetyl-CoA since all glucose-carbons are
net lost as CO2, while glucose oxidation in the pentose phosphate pathway is incomplete
(partial) due to the loss of only one carbon atom from glucose molecule and the
subsequent formation of ribose. Before glucose entry to the Krebs cycle it undergoes
glycolysis. Glycolysis in the GIT and muscle does not commit glucose carbon to
oxidation since the three-carbon intermediates lactate and alanine can be formed and
recycled to glucose in the liver. However, if pyruvate enters into the Krebs cycle via
oxaloacetate or malate through anaplerosis acetyl-CoA this leads to a net loss of glucose
carbon because for every pyruvate molecule entering the cycle one carbon is lost at
pyruvate dehydrogenase and two more carbon atoms are lost at isocitrate dehydrogenase
and α–ketoglutarate dehydrogenase steps.
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Adaptations in glucose metabolism can occur in response to dietary (Harmon et
al., 1986) and physiological status (Okine et al., 1995). Rumen epithelial tissues from
steers fed a high concentrate diet utilized more glucose by also produced more lactate and
CO2 than tissues from roughage fed steers (Harmon, 1986). Also in enterocytes lactate
and CO2 production from glucose were found to be higher in early-lactation cows as
compared to mid and late-lactation cows (Okine, 1995).
One aspect that remains unresolved is the extent that glucose is oxidized for
energy production. In most studies, [U-14C]glucose tracer was used which does not allow
differentiating between complete oxidation, i.e. Krebs cycle metabolism, or partial
oxidation as it is the case in the pentose phosphate pathway. However, using [1-
14C]glucose and [6-14C]glucose tracers it was demonstrated that pig enterocytes partial
oxidation of glucose via the pentose phosphate pathway dominated over Krebs cycle
metabolism (Wu et al., 1996). In the latter study, however, glucose was the only substrate
included in the incubation media, and this would never be the situation in vivo. In other
reports (Harmon, 1986; Okine et al., 1995; Oba et al., 2004), where a more complete
array of substrates are present, there seems to be agreement that glucose catabolism is
reduced when substrates such as SCFA (Harmon et al., 1986; Oba et al., 2004) or AA
(Okine et al., 1995) are added to the incubations as treatments.
Intermediary metabolism
Lactate and alanine are the most important metabolic end products of glucose
metabolism in GIT. Most lactate originates from glycolysis rather than propionate
metabolism in sheep (Weeks and Webster 1975; Reynolds et al., 1991). Between 0.40-
0.45 of lactate produced by the small intestines of sheep derives from arterial glucose
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whereas on a whole body basis glucose contributes only 0.28-0.39 of lactate production
(Janes et al., 1985). Similarly, in pregnant ewes, >50% of lactate produced by the PDV
derives from arterial glucose (van der Walt et al., 1983; Reynolds et al., 1991), with the
remainder derived from substrates that contain at least 3 carbons.
It was suggested that the high rates of glycolysis in rapidly growing cells is
therefore likely to occur to maintain high levels of glucose-6-phosphate required for
ribose synthesis (Newsholme et al., 1985). Data from pig studies support this view, as it
has been shown that glucose oxidation by the pentose phosphate pathway is about 10 ×
higher than by the Krebs cycle (Wu et al., 1996). The end product of glycolysis, pyruvate,
is reduced to lactate as a salvage mechanism and recycled to the liver for resynthesis of
glucose.
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Gluconeogenesis is the process by which glucose is formed from “non-hexose”
precursors (Nelson and Cox, 2000). Therefore, gluconeogenic precursors, by definition,
are those metabolic intermediates whose carbon skeleton does not originate from glucose.
Where glucose is synthesized from glucose metabolic end-products, this process is
termed “glucose recycling”.
In general, the most important gluconeogenic precursors include those whose
metabolism results in a net gain of carbon atoms in glucose. Thus, substrates metabolized
via acetyl-CoA do not make a net carbon contribution because the resulting acetyl-CoA
condenses with a molecule of oxaloacetate to yield a molecule of citrate. Subsequently,
the carbons from acetyl-CoA are conserved after one turn of the cycle but at the same
time two molecules of carbon dioxide are generated at the isocitrate dehydrogenase and
α-ketoglutarate dehydrogenase steps. In consequence, the net balance of carbon resulting
from inputs into the acetyl-CoA pool is neither a gain nor a loss of carbon from the Krebs
cycle.
Although most amino acids, glycerol and lactate contribute net carbon to
gluconeogenesis, in ruminants propionate (Leng et al., 1967) and alanine (Wolff and
Bergmann, 1972) are quantitatively the most important. Liver removal of propionate
from portal blood accounts for up to 90% of propionate absorbed from the rumen
(Armentano, 1992). These removal rates, combined with a high hepatic propionyl-CoA
activity, explain the large contribution of propionate to gluconeogenesis (Leng et al.,
1967; Chow and Jesse, 1992). The additional benefit of feeding grains to ruminants is the
increased contribution of propionate and that of absorbed glucose to glucose turnover rate
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(0.08 vs. 0.60; Janes et al., 1985). Other substrates also contribute to gluconeogenesis for
which alanine accounts for 10%, lactate 2 to 9%, and amino acids other than alanine 17-
24% (Reynolds et al., 1991). However, lactate and alanine utilization for gluconeogenesis
derive, in part, from glucose catabolism, representing a portion of glucose carbon
recycling.
The rate of gluconeogenesis decreases significantly when glucose absorption from
the small intestines is increased by feeding high grain diets. Corn supplementation to
dried grass diets increased the contribution of absorbed glucose to glucose entry rate from
8% to 60% in sheep (Janes et al., 1985). It is important however for the additional starch
source to escape rumen fermentation. If this is not the case, then rumen fermentation will
ultimately increase hepatic glucose production through gluconeogenesis from propionate
(Leng et al., 1967).
Amino acids are oxidized by the GIT, and this oxidation occurs via entry to the
Krebs cycle. Glucose oxidation in the cycle via acetyl-CoA (i.e. sparing Leu, Lys) or via
oxaloacetate (i.e. sparing AA entering prior to oxaloacetate) should lead to a reduction in
AA catabolism, consequently increase AAs post-absorptively. Whether dietary changes
leading to increased glucose absorption and/or increasing gluconeogenesis will supply
more glucose to the GIT, hence have a sparing effect on AA utilization for oxidative
purposes, is conditional upon glucose being oxidized for energy production via the Krebs
cycle.
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Short chain fatty acids
Short chain fatty acids (SCFA) are produced mainly in the gastrointestinal tract of
ruminants and simple stomached animals as by-products of microbial fermentation of
dietary carbohydrates (van Houtert, 1993). Although dietary proteins digested in the
rumen contribute to SCFA production, this contribution is less significant in ruminants
fed forage only diets (Bergman 1990; Britton and Krehbiel 1993; France and Siddons,
1993; van Houtert 1993).
Combined, SCFA represent about 0.75 of the metabolizable energy derived from
fermentation of feed carbohydrates, and are comprised of mainly acetate, propionate and
butyrate (0.95 of total SCFA; Bergman 1990; Britton and Krehbiel 1993; van Houtert
1993). Despite being by-products of rumen fermentation, SCFA are essential as they
contribute 0.60-0.80 to ruminants’ energy needs (Bergman, 1990; van Houtert, 1993).
Short chain fatty acids are produced in large amounts during rumen fermentation that
their constant removal and transport are important for the survival of the animal.
Production and absorption
The molar ratios of SCFA vary as a function of rumen supply of dietary
ingredients. Diets that are high in forages (90%) generally produce a higher proportion of
acetate to total SCFA produced (70:15:10) when fermented in the rumen because long
forages favor the growth of acetate producing bacteria whereas concentrate (90%) based
diets favor the production of propionate (55:30:12) at the expense of acetate (Harmon et
al., 1991). Feeding time, quality of the dietary forage, level of intake and dietary
additives affect this ratio and the total concentration and production rate of SCFA
production (Bergman et al., 1990; France and Siddons, 1993).
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Normally the pH of the rumen ranges between 6-7 at which most SCFA (weak
acids; pKa ~4.8) are present in the dissociated form in the rumen fluid (Bergman, 1990;
van Houtert, 1993). Short chain fatty acids are absorbed in the dissociated form across the
apical aspect of rumen epithelial cells through a bicarbonate/acid exchanger (Gäbel et al.,
2002). Under normal feeding conditions only a small proportion (<0.10) of ruminally
produced SCFA reach the small intestines (Bergman, 1990; Gäbel et al., 2002). Once
absorbed into the rumen epithelial cells, SCFA can be oxidized to CO2 or metabolized to
ketone bodies, or they are absorbed and released into the venous blood draining the
gastrointestinal tract.
Metabolism of short chain fatty acids
The carbon skeleton of SCFA are used either for energy production in the Krebs
cycle or they are metabolized to lactic acid and the ketones acetoacetate and β-
hydroxybutyrate (Figure 1.5). The first step in SCFA metabolism involves the activation
of the fatty acid by conjugation with coenzyme A (CoA). Acyl-CoA synthetase is the
limiting step for SCFA catabolism and oxidative degradation (Figure 1.4) and it is
believed this enzyme serves as the point of metabolic control (Cook et al., 1969; Ash and
Baird, 1973).
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Differences exist with respect to tissue acyl-CoA synthetase activity and the
specificity of the acyl-CoA towards a SCFA. acetyl-CoA and propionyl-CoA synthetase
activity in rumen epithelial tissue of calves are 0.10 and 0.64 that of butyryl-CoA
(Harmon et al., 1991). In that study, the addition of butyrate to incubation media
decreased the acetyl-CoA and propionyl-CoA synthetase activities by 0.63 and 0.82,
whereas acetate and propionate had no effect on butyryl-Co synthetase activity. The
significance of the distribution of –CoA synthetases relates to the role of the GIT and
liver in regulating the appearance and delivery of the SCFA to peripheral tissues (e.g.
muscle, mammary, adipose).
It has been proposed that the overall result of acyl-CoA synthetase activity and its
specificity in the rumen and liver is to ensure that acetate is removed by peripheral
tissues, that butyrate is metabolized to β-hydroxybutyrate by the rumen epithelium. that
propionate is removed by the liver and that acetate reaches the peripheral tissues (Ash
and Baird, 1973). The metabolism of butyrate to β-hydroxybutyrate is believed to be a
protective mechanism against the hyperglycemic effect of butyrate, which causes the
secretion of glucagon from the pancreas, while acetate, propionate and β-hydroxybutyrate
have a lesser effect (see Cook et al., 1969). Ketogenesis in the rumen wall serves other
functions such as the creation of a favorable concentration gradient for butyrate
absorption across the rumen epithelium and for conserving most of the energy of the
parent SCFA (Henning and Hird, 1972).
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It is widely accepted that in ruminants 0.30 of acetate, 0.50 of propionate and 0.90
of butyrate produced in the rumen is metabolized by stomach tissues (Bergman, 1990).
The extents that acetate and propionate are metabolized by rumen tissues is controversial.
Some studies have reported extensive metabolism of acetate and propionate (0.30-0.50,
for reviews see Bergman, 1990; Britton and Krehbiel, 1993; van Houtert, 1993; Rémond
et al., 1995) while others have reported very little degradation by rumen tissues (0.10-
0.15, Kristensen et al., 2000b).
Recently, the washed rumen technique has been employed to distinguish between
metabolism of SCFA by rumen tissues versus that by bacteria adhering to the rumen
epithelium. Here, it was concluded that microbial metabolism accounts for most of the
“loss” of SCFA between the rumen tissues and the blood. The results of a series of
experiments (Kristensen et al., 1996; Kristensen et al., 2000ab; Kristensen and Harmon,
2004ab) provides evidence that a small proportion of propionate (0.05-0.10) is
metabolized during absorption whereas acetate is not metabolized and acetate infused in
the rumen is recovered across the rumen wall in the portal blood drainage. In that study,
only butyrate was found to be metabolized by the rumen tissues with 0.18-0.82
catabolized.
While the metabolic fates of acetate and propionate have been questionable, the
metabolic fates of butyrate have so far been conclusive in that a large (0.70-0.90)
proportion of ruminal butyrate is metabolized to β-hydroxybutyrate by rumen wall
(Bergman, 1990; Kristensen et al., 2000b; Nozière et al., 2000). The different techniques
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employed to quantitate SCFA metabolism may explain some of the differences observed
in the literature and this creates difficulties for making comparisons among studies.
Employing carbon (14C, 13C) tracers, it is possible to determine the fates of the
carbon skeletons of SCFA, their catabolism to CO2, lactate and ketone bodies. This is an
advantage over non-tracer methods where the net inputs and outputs are measured and
does not allow accounting for the exchanges and interconversion of carbon skeletons
between metabolites in animal tissues.
In ruminants, small intestinal cells are exposed to SCFA escaping the rumen and
those derived from the arterial blood (Bergman, 1990; Gäbel et al., 2002). The amounts
of SCFA presented to the small intestine are lower (7-14 vs 84-109 mmol/L) than those
presented to rumen epithelial cells (Rupp et al., 1994), yet they have been shown to alter
enterocytes metabolism. Propionate and butyrate have been shown to reduce glucose and
glutamine oxidation in isolated sheep enterocytes (Oba et al., 2004).
In summary, studies in the literature raise a question: is the concept of SCFA
metabolism by the rumen wall valid or is it an artifact of the techniques used? Clearly the
contribution of microbial metabolism leads to an overestimate of the tissue’s metabolism,
and therefore, an overestimate of the energetic requirements of the animal. However,
when microbial metabolism is taken into account rumen metabolism of propionate (0.10)
and butyrate (0.5-0.7) still occurs (Kristensen and Harmon, 2004ab). Furthermore, the
supply of SCFA alters enterocytes metabolism and has an influence on glucose and AA
utilization by the GIT (Harmon, 1986; Oba et al., 2004). Whether SCFA metabolism
occurs for energy production requires further elucidation.
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ABSTRACT
Gastrointestinal (GIT) metabolism of glucose was investigated in sheep (n=6, 35 ± 2.0
kg) fed a low protein diet (100 g CP/kg) to 1.6× maintenance. Catheters were fitted for
duodenal infusion and flux measurements by the portal-drained viscera. Animals were
given 10-d duodenal infusions of either glucose (50 g/ d, Control) or Glucose (50 g/ d) +
Casein (60 g/d) in a cross-over design. On days 7 and 10, [1-13C]glucose was infused (6
h) into either a jugular vein or the duodenum to determine glucose utilization by the GIT.
The GIT utilized 48-51% of glucose available from absorption and gluconeogenesis.
Most of the glucose used by the GIT derived from the arterial circulation (65-82%)
compared to that from the GIT lumen(18-35%). Compared to Control, Casein + Glucose
increased (P<0.05) the contribution of luminal (first-pass) and decreased (P<0.05) that of
arterial glucose utilization by the GIT, but total GIT utilization remained the same.
Casein + Glucose infusion increased (P<0.05) total glucose availability, however, this
derived mainly from an increase in gluconeogenesis (+27%).
Keywords: glucose, gastrointestinal, sheep
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INTRODUCTION
Gastrointestinal tract (GIT) metabolism by ruminants places a major drain on
amino acid (AA) and glucose for growth. Metabolism of intestinal essential AA supply is
high (0.25-0.60, MacRae et al., 1997b), as is non-essential AA metabolism (80-100%,
Heitmann and Bergman, 1981). Similarly, a significant proportion (0.40-0.60) of
intestinal glucose is removed by the GIT (Cappelli et al., 1997). Reducing the catabolic
losses of AA and glucose by the GIT is a goal towards improving N and energy
efficiency of ruminants. In this respect, our aim is to determine the optimal pattern of
substrates for productive processes, and this requires knowledge of the fuels selected by
the GIT for metabolism.
Based on previous studies with ruminal and intestinal cells, where metabolic
flexibility was demonstrated for AA and glucose oxidation (Okine et al., 1995; Oba et al.,
2004), we hypothesized that if AA, and not glucose, are the preferential energy substrates
of the GIT, then intestinal infusion of casein would lead to a reduction in glucose use by
the GIT.
MATERIALS AND METHODS
The Institutional Animal Care and Use Committee at the University of Maryland
approved all animal use procedures. Six sheep (4 Katahdin and 2 Dorset x Polypay, 35 ±
2.0 kg) were fitted with chronic catheters placed into the duodenum, an artery, the
hepatic-portal and two mesenteric veins. After recovery, sheep were placed in metabolic
crates and fed a pelleted diet by automatic feeder (12 × 2-h intervals). The diet was fed to
1.6 × maintenance energy requirements (NRC, 1985), and was low in protein (100 g
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CP/kg) but energy adequate (7.5 MJ metabolizable energy/kg). Animals were arranged in
a balanced cross over design with 10-d treatment periods. Treatments were duodenal
infusion of either glucose (50 g/ d, Control) or Glucose(50g/d) + Casein (60 g/d).
On days 7 and 10 of each period, [1-13C]glucose was infused (200 mg/h for 6 h)
into either a jugular vein or the duodenum to determine the rate and proportion of glucose
entry utilized by the GIT and to distinguish between luminal and arterial utilization of
glucose. Plasma flow was determined by infusion (15 mg/ min, pH 7.4) of p-
aminohippuric acid into the distal mesenteric vein. During the last 4 h, blood was
continuously withdrawn from each vessel over 1-h periods into sealed syringes
submerged in an ice bath. Samples were mixed and processed for analysis.
Plasma glucose enrichment and concentration were determined by gas
chromatography-mass spectrometry under electrical impact mode (Hannestad and
Lundblad, 1997, Calder et al., 1999). Plasma concentrations of p-aminohippuric acid were
determined as previously described (McRae et al., 1997b). Gravimetric procedures were
used throughout to reduce error and increase precision.
Data were analyzed using the MIXED procedure of SAS (2003), with sheep,
period, breed, and treatment order considered as random effects. Differences were
considered significant at P≤0.05.
Plasma glucose entry rate was calculated for jugular vein (GEjv) and duodenal
(GEduo) [1-
13C]glucose infusions employing standard isotope dilution principles.
Fractional splanchnic removal was calculated as: 1-( GEjv/ GEduo). Net flux (absorption or
removal) of glucose by the PDV was calculated as the product of plasma flow (PF) and
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arterio-venous concentration difference. Fractional utilization of arterial glucose (fa) was
based upon jugular infusion of [1-13C]glucose calculated by:
where E is enrichment, and [A] and [V] are concentrations of glucose in artery
(A) and portal vein (V). Arterial glucose utilization was calculated as: [A] × PF ×
fractional utilization of arterial glucose. Luminal use of glucose (i.e. first-pass) was
calculated from recovery of [1-13C]glucose infused into the duodenum after correction for
second-pass arterial removal, and converted to an absolute rate based on unlabeled
glucose infusion rate into the duodenum:
RESULTS
There were no significant differences detected in glucose metabolism between
Katahdin and Dorsett × Polypay sheep. Plasma glucose (Table 2.1) and glucose entry
rates based on jugular and duodenal tracer infusion were not significantly affected by
Casein + Glucose infusion compared to infusion of glucose alone (Control). Portal
plasma flow tended (P<0.08) to be lower with Casein + Glucose infusion. Arterial use of
glucose by the GIT accounted for 65-82% and luminal use 18-35% of total GIT use of
glucose. Total utilization of glucose by the GIT was not affected; however, infusion of
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reduced (P<0.05) contribution from the arterial supply and an increased (P<0.05)
contribution from the gut lumen (first-pass). First-pass metabolism of glucose by the GIT
accounted for 33 to 62% of the glucose infused into the duodenum, and this was reflected
in a tendency (P<0.08) for [1-13C]glucose recovery across the PDV to be lower with
Casein + Glucose. Total glucose availability (gluconeogenesis + luminal absorption) was
greater (P<0.05) with Casein + Glucose infusion, and after correction for luminal glucose
absorption, indicated that gluconeogenesis increased with Casein + Glucose. Utilization
of glucose by the GIT (arterial + luminal) accounted by 48 to 51% of glucose available
from absorption plus gluconeogenesis, and this was not altered by treatment.
DISCUSSION
Many previous studies in ruminants have demonstrated that GIT metabolism
places a major drain on AA and glucose availability for peripheral tissue anabolism. In
this respect, there are two questions with regards to AA and glucose metabolism by the
GIT: Is GIT metabolism of these nutrients obligate? To what extent are these nutrients
metabolized from the gut lumen versus metabolism from the arterial circulation? We
(Oba et al., 2004) and others (Okine et al., 1995) have demonstrated with ruminal and
duodenal cells in vitro that the gut tissues of ruminants have some metabolic flexibility to
oxidize either glucose or AA (glutamate, glutamine) for energy. In the present study, we
tested, by increasing the supply of protein (casein) to the small intestines of sheep fed a
marginally low protein but energy adequate diet, whether glucose metabolism by the GIT
is ‘spared’ by provision of AA. Our results indicate that total GIT use of glucose is not
affected by additional luminal AA supply, and so under these conditions glucose
metabolism by the GIT was obligatory. However, this disguised the fact that casein
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infusion increased the amount and proportion of glucose use by the GIT that was derived
from the gut lumen supply (3.9 vs. 7.2 mmol/h, 18% vs. 35%) and decreased the
proportional use from the arterial supply (82% vs 65%). Further, casein infusion on this
low protein diet increased total glucose availability from luminal absorption and
gluconeogenesis, which after correction for luminal absorption indicated that casein
infusion increased gluconeogenesis by 27%.
Nutrients are delivered to the GIT from luminal and arterial supplies, and thus the
factors regulating use from these sources will differ. Our results indicate that glucose use
by the ruminant GIT derives mainly (65-82%) from the arterial circulation, which is
probably under hormonal control and suggests that the GIT may be in competition with
peripheral tissues (eg. muscle, mammary gland) for glucose supplies. Partition
predominantly from the arterial circulation has also been observed for essential AA,
where for most AA ∼80% of GIT use of AA derived from the arterial circulation MacRae
et al., 1997a). This pattern of glucose and AA use also corresponds with the known
distribution of luminal absorptive capacity of the ruminant GIT with only ∼20% of the
luminal surface of the GIT capable of glucose and AA transport and absorption.
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TABLE 2.1.
Whole body and gastrointestinal tract metabolism of glucose in sheep given







Plasma glucose flux and metabolism
Arterial glucose (mM) 3.84 (6) 3.94 (6)1 0.490 0.59
Glucose entry rate (mmol/h)
Jugular [1-13C]glucose infusion (A) 37.6 (6) 43.4 (6) 3.01 0.13
Duodenal [1-13C]glucose infusion (B) 45.0 (6) 48.2 (6) 5.75 0.47
Fractional splanchnic removal (1-(A/B)) 0.21 (5) 0.17 (5) 0.100 0.83
Gastrointestinal glucose metabolism
Portal plasma flow (g/min) 1880 (5) 1270 (6) 217 0.08
Glucose utilization
Net flux2 (mmol/h) 81.3 (5) -19.3 (6) 55.00 0.16
Arterial use (mmol/h) (C) 13.6 (5) 16.3 (5) 3.72 0.62
Luminal use (mmol/h) (D) 3.9 (4) 7.2 (5) 0.79 0.01
Total gut use (mmol/h) (E) 21.0 (4) 23.0 (5) 5.49 0.78
Fractional luminal tracer recovery 0.65 0.45 0.134 0.15
Fractional arterial use of total gut use4
(C/E) 0.82 (4) 0.65 (5) 0.071 0.03
Fractional luminal use of total gut use
(D/E) 0.18 (4) 0.35 (5) 0.071 0.03
Total glucose availability5 (TGA; mmol/h) 37.1 (5) 47.7 (5) 5.11 0.04
Luminal use as % of TGA 11.2 (4) 15.6 (5) 2.78 0.08
Arterial use as % of TGA 34.9 (5) 34.0 (5) 8.78 0.94
Total gut use as % of TGA 51.0 (4) 48.0 (5) 13.14 0.81
1 Number of observations (n).
2 Negative values indicate net removal and positive values net absorption.
3 For both treatments, fractional arterial use was greater than fractional luminal use (at
least P<0.05).
4 The fractional contribution to total gut glucose use from arterial removal was
significantly greater (P<0.01) than that from luminal use.
5 TGA = glucose entry rate (jugular [1-13C]glucose infusion) + first-pass luminal use.
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CHAPTER 3
INTESTINAL PROTEIN SUPPLY ALTERS AMINO ACID, BUT NOT
GLUCOSE, METABOLISM BY THE SHEEP GASTROINTESTINAL TRACT
Published in:




This study aimed to establish the extent which amino acids (AAs) and glucose are net
metabolized by the gastrointestinal tract (GIT) of ruminant sheep when intestinal protein
supply is varied. Wether sheep (n = 4, 33 ± 2.0 kg) were fitted with catheters for
measurement of net absorption by the mesenteric (MDV) and portal-drained (PDV)
viscera, and a catheter inserted into the duodenum for casein infusions. Sheep received a
fixed amount of a basal diet that provided adequate metabolizable energy (10.9 MJ/d) but
inadequate metabolizable protein (75 g/d) to support 300 g gain per day. Four levels of
casein infusion (0 (water), 35, 70, & 105 g/d), each infused for 5.5 d, were assigned to
sheep according to a 4 × 4 Latin square design. [methyl-2H3]Leucine was infused (8 h)
into the duodenum while [1-13C]leucine plus [6-2H2]glucose were infused (8 h) into a
jugular vein. With the exception of glutamate and glutamine, net absorption of AAs
increased linearly (P < 0.05, R2= 0.46 to 1.79 for MDV; P < 0.05, R2 = 0.6 to 1.58 for
PDV) with casein infusion rate. Net absorption by the PDV accounted for <100% of the
additional supplies of leucine, valine and isoleucine (0.6 to 0.66, P < 0.05) from casein
infusion, whereas net absorption by the MDV accounted for 100% of the additional
essential AA supply. Glucose absorption (negative) and utilization of arterial glucose
supply by the GIT remained unchanged. There was a positive linear (P < 0.05) relation
between transfer of plasma urea to the GIT and arterial urea concentration (MDV, P <
0.05, r = 0.90; PDV, P < 0.05, r = 0.93). The ruminant GIT appears to metabolize
increasing amounts of the branched-chain AAs and certain non-essential AAs when the
intestinal supply of protein is increased.
Key words: sheep, gastrointestinal tract, amino acid, urea, glucose.
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INTRODUCTION
In ruminants, metabolism by the gastrointestinal tract (GIT)1 represents the single
largest metabolic fate of amino acids (AAs), glucose and other energy substrates in the
body. Depending upon the AA, the GIT metabolizes 5 to 100% of the AA supply
disappearing from the small intestines, and for glucose 50 to 100% of its intestinal
disappearance (MacRae et al., 1997a; MacRae et al., 1997b; Berthiaume et al., 2001).
The nutritional significance of GIT metabolism is well known, yet there are still
important aspects of GIT metabolism that remain largely unresolved. In regards to AA
metabolism, it could be hypothesized that, at a minimum, net metabolism of essential
AAs by the GIT occurs at a fixed rate and amount relative to their compositions in the
endogenous proteins lost from the GIT. Thus, once this ‘service cost’ is satisfied,
absorption of AAs across the GIT should approximate to100% of their additional
intestinal supplies. Current information suggests that this may not be the case, however,
in particular with regards to certain non-essential AAs (Caton et al., 2001; Reynolds et
al., 1991; Stoll et al., 1999; Bos et al., 2003; van der Schoor et al., 2001; Windemueller
and Spaeth, 1980).
Net absorption of AAs by the small intestines of ruminants has been determined
from the product of net arterio-venous difference and blood flow measurements across
the mesenteric-drained viscera (MDV). Most often, however, net metabolism by the
whole GIT is determined from measurements across the portal-drained viscera (PDV),
which represents the sum of MDV plus rumen and hind-gut metabolism. This measure
1 Abbreviations used: AA, amino acid; PAH, p-amino-hippuric acid;APE, atom percent excess; t-BDMS, t-
butyldimethylsilyl; BCAA, branched chain amino acids; F, flow; GC-MS, gas chromatography -mass
spectrometry; GIT, gastrointestinal tract; MDV, mesenteric drained viscera; PDV, portal drained viscera.
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accounts for intestinal metabolism as well as that occurring by the rumen and hind-gut
tissues the latter of which derive AAs almost exclusively from the arterial blood supply
(MacRae et al., 1997). Although this arterial use of AAs by the PDV is considered a
consequence of GIT metabolism, this arterial use of AAs represents potential competition
with peripheral tissues (e.g. muscle, mammary gland). Based on PDV net flux
measurements (dairy cows: Berthiaume et al., 2001; Caton et al., 2001; Reynolds et al.,
2001; sheep: MacRae et al., 1997) net recovery of infused casein or free AAs or absorbed
essential AAs is generally found to be lowest for the branched chain AAs (BCAA:
leucine, valine and isoleucine; 10-62%), followed variously by methionine (33-69%),
histidine (39-92%), phenylalanine (36-96%), lysine (30-66%), tryptophan (31-88%) and
threonine (41-63%). By contrast, intestinal supplies of the non-essential AAs glutamine
and glutamate have been found to be almost completely metabolized by the GIT, even
when the supplies of these AAs are increased (Caton et al., 2001; Reynolds et al., 1991;
Stoll et al., 1999; Bos et al., 2003; van der Schoor et al., 2001; Windemueller and Spaeth,
1980). These studies examined PDV nutrient use in response to only one level of protein,
AAs or feed intake, and so it has not been possible to establish response relationships of
intestinal supply and net absorption of individual AAs. In consequence, it is not known
whether GIT metabolism occurs at a fixed or variable rate for individual AAs, and nor is
it known whether this GIT metabolism ultimately leads to differential supplies of AAs to
the liver and beyond to peripheral tissues for anabolic use.
The aim of this study is to answer two central questions regarding AA utilization
by the ruminant GIT: 1) are certain AAs preferentially utilized? and 2) are certain AAs
metabolized at fixed or variable rates relative to changes in their intestinal supply? A
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secondary aim relates to observations that the GIT of ruminants net metabolizes the
intestinal supply of glucose (Reynolds et al., 1988, Reynolds et al., 1991). For this
reason, the net balance of glucose across the GIT is often negative. In this respect, an aim
was to determine whether glucose utilization is reduced or unaffected by changes in the
intestinal supply and GIT utilization of AAs.
MATERIALS AND METHODS
Sheep and Surgery. The experimental protocol was approved by the Institutional
Animal Care and Use Committee at the University of Maryland (College Park, MD).
Four mixed-breed (Polypay × Dorsett, 33 ± 2.0 kg body weight, 5 to 6-mo-old) wether
lambs were prepared under general anesthesia with vascular catheters (Silastic®, 0.64
mm i.d., 1.19 mm o.d.) placed in the distal and proximal mesenteric vein, the hepatic
portal vein and a femoral artery. The tip of the proximal mesenteric vein blood sampling
catheter was positioned ~5 cm from the ileo-cecal vein junction at the most proximal
point where the venous drainage from proximal small intestine enters the mesenteric
arcade (see Seal and Reynolds, 1993). The tip of the distal mesenteric vein catheter was
positioned ~30 cm upstream of the proximal catheter for infusion of the blood flow
marker para-aminohippuric acid (PAH). A catheter (polyvinyl chloride, 2.4 mm i.d. × 4.0
mm o.d.) was also inserted into the proximal duodenum, the tip ~10 cm from the pylorus,
for infusion of casein. From 2 wk post-surgery, feed (Table 3.1) was delivered in equal
portions every 2 h via an automatic feeder. Sheep were fed to two times energy
maintenance intake (10.9 MJ/d, ~80 g dry matter/kg body weight0.75) a pelleted ration
that was adequate in energy (calculated 10.2 MJ metabolizable energy/kg dry matter) but
which was low in protein (10.4% crude protein, dry matter) and provided only ~60% of
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the metabolizable protein intake (~75 g/d) required to support 300 g of gain per day
(AFRC, 1992).
Casein infusion. Sheep were placed in individual metabolic crates
equipped with automatic feeders and fresh water was provided daily. Sheep were
randomly assigned to four levels of casein infusion (0, 35, 70 and 105 g/d in 1.0 L water)
according to a balanced 4 × 4 Latin Square design. Rates of casein infusion were
designed to increase metabolizable protein supply from 60% (Control, 75g/d) to 110%
(180 g/d, 105 g casein/d level) of that required to support 300 g/d gain (AFRC, 1992).
Each period lasted 10 d, with casein infused during the last 5.5 d. On day 1 and 3 of each
10-d experimental period, sheep were allowed to exercise in floor pens for at least 2 h/d.
In addition, a 1-wk rest period (for exercise) in floor pens separated periods 2 and 3.
Tracer infusion and blood sampling. On day 4 of casein infusions, a temporary
catheter (polyvinyl chloride, 0.8 mm i.d., 1.20 mm o.d.) was inserted (10 cm) into a
jugular vein. On the last day, a sterile solution containing PAH (0.1 mol/L) and heparin
(235 IU/mL) was infused (8 h, 20 mL/h) into the distal mesenteric vein catheter, and into
the jugular vein was infused (8 h, 20 mL/h) a sterile solution containing [1-13C]leucine
(1.5 mg/mL) and [6-2H2]glucose (5 mg/mL). At the same time, [methyl-
2H3]leucine (30
mg/h) was infused into the duodenum along with water or casein infusions. Over the last
4 h, blood samples were continuously withdrawn (5 mL/h) over 1-h periods from the
artery, proximal mesenteric vein and portal vein by peristaltic pump and collected into
sealed syringes submerged in an ice-bath. Each syringe was mixed by gentle hand-
rolling, and plasma separated by centrifugation (1000 ×g for 15 min at 4°C).
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Plasma amino acid and urea concentration. These were determined by isotope
dilution with gas chromatography-mass spectrometry (GC-MS) as previously described
(Calder et al., 1999). To a known weight (0.5 g) of fresh plasma was added an equal
known weight of a solution containing 0.2 mg hydrolyzed [U-13C]algae protein powder
(99 atoms %; Martek Biosciences Corp., Columbia, MD), 100 nmol [indole-
2H5]tryptophan, 200 nmol [5-
15N]glutamine, 25 nmol [methyl-2H3]methionine, and 3
µmol [15N2]urea, and the samples stored frozen (-20°C). Thawed samples were
deproteinized by addition (1 mL) of sulfosalicylic acid (15% w/v), the supernatant
desalted by cation (AG-50, H+ form) exchange, and AAs and urea eluted with 2 mol/L
NH4OH followed by water. For urea analysis, 20 µL of this eluate was dried under a
stream of N2, and urea converted to the t-butyldimethylsilyl (t-BDMS) derivative prior to
GC-MS (HP 5973N Mass Selective Detector, Agilent, Palo Alto, CA). The remaining
eluate was lyophilized to dryness, and AAs converted to their t-BDMS derivative. Under
electron impact mode, the following ions (m/z) were monitored: urea 231, 233; alanine
260, 263; glycine 246, 248; valine 288, 293; isoleucine 302, 308; proline 286, 291;
methionine 292, 295; serine 390, 393; threonine 404, 408; phenylalanine 234, 242;
aspartate 302, 304; glutamate 432, 437; lysine 300, 306; histidine 440, 446; glutamine
168, 169; tyrosine 302, 304; and tryptophan 244, 249. For leucine isotope enrichment and
concentration, ions at 302, 303 ([1-13C]leucine), 305 ([2H3]leucine) and 308
([13C6]leucine, internal standard) were monitored. Calibration curves were generated
from gravimetric mixtures of labeled and unlabeled AA. For leucine, correction was also
made for the spillover of [1-13C]leucine (m/z 303) into [2H3]leucine (m/z 305), and
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spillover of [2H 3]leucine into [
13C6]leucine (m/z 308). All enrichments were expressed as
atoms percent excess (APE) relative to background natural abundance.
Glucose concentration and enrichment. To a known weight (0.150 g) of fresh
plasma was added an equal known weight of a solution containing 0.6 mmol
[13C6]glucose. The aldonitrile pentaacetate derivative of glucose was formed (Hannestad
and Lundblad, 1997), and ions at 242, 244 ([2H2]glucose) and 247 ([
13C6]glucose)
monitored by GC-MS under electrical impact mode. This derivative of glucose loses
carbon-1 under electron impact to yield m/z 247 which corresponds to the internal
standard [13C6]glucose. Calibration curves were generated, and corrections made for spill-
over of m/z 244 ([2H2]glucose) to m/z 247 ([
13C6]glucose). Enrichments are expressed as
APE above background.
PAH concentration. Plasma concentrations of PAH were determined in duplicate
using 0.25 g plasma and employing gravimetric procedures (Bequette et al., 1996).
Calculation of net fluxes of amino acids. Net absorption or removal of an AA by
the mesenteric (MDV; mostly small intestines) and portal (PDV; whole GIT) drained
viscera was calculated as the product of plasma flow (F; (kg/(kg BW • h) and plasma
veno-arterial concentration difference (µmol/kg plasma) as appropriate. The incremental
recovery by the MDV and PDV of individual AAs infused as casein into the duodenum
was determined from the slope of the regression of net flux rate against duodenal casein-
AA infusion rate (µmol/(kg BW • h). The intestinal digestibility of casein was assumed to
be 100% (Stoll et al., 1998).
Calculation of leucine fluxes. Rate leucine of appearance (Leu Ra) was
calculated from arterial plasma leucine enrichment (EA) when the leucine tracer was
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infused into the jugular vein ([13C]leucine; systemic Leu Ra) or into the duodenum
([2H3]leucine; whole body Leu Ra):
Leu Ra = [(EI / EA)-1] × IR
where EI is the APE of the leucine tracer infused ([
2H3] or [1-
13C]), and IR is isotope
infusion rate per kg BW per h. The difference between whole body Leu Ra and systemic
Leu Ra is leucine removed by the gut and liver during its first-pass. Fractional first-pass
arterial utilization of leucine by the MDV or PDV was calculated from jugular infusion of
[13C]leucine:
Fractional arterial utilization = ([A] × EA − [V] × EV )/([A] × EA)
where [A] is arterial and [V] is MDV or PDV concentration of leucine as appropriate.
First-pass arterial utilization by the MDV or PDV was calculated as:
First-pass arterial utilization = [A] × F × fractional arterial utilization
where F is plasma flow rate for the MDV or PDV as appropriate. Fractional first-pass
intestinal utilization of leucine was computed from [2H3]leucine tracer balance across
the PDV, corrected for [2H3]leucine recycled and sequestered on second-pass by the
PDV from the arterial circulation (i.e. [13C]leucine arterial removal):
Fractional first-pass intestinal utilization =
(([V] × EV) − ([A] × EA) + ([A] × EA × fractional arterial utilization × F))/IR
where IR is the rate of [2H3]leucine infusion into the duodenum.
Calculation of glucose utilization. Net removal of plasma glucose by the MDV
and PDV was calculated as above for AAs. Glucose rate of appearance (gluconeogenesis,
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glucose recycling and absorption) was calculated as described for Leu Ra. First-pass
arterial utilization of glucose by the MDV and PDV was calculated as:
First-pass arterial glucose utilization = (([A]×EA − [V]×EV ) / ([A]×EA)) × [A] × F
where E is the enrichment (APE) of [2H2]glucose in the artery (A) and vein (V; MDV or
PDV).
Statistical analysis. For all data, ANOVA assumptions were checked prior to
analysis. Data were analyzed by three-way ANOVA for a 4×4 Latin square design using
the MIXED procedure of SAS (version 8.0, SAS Institute, Cary, NC) in which the
infusion level was the fixed effect and sheep and experimental period are random effects.
The following linear mixed model was used:
Yijk = µ + Ti + Rj + Ck + εijk
Where Yijk is the observed value for the k
th sheep, the jth period and the ith treatment, µ is
the grand mean, Ti is the treatment effect for the i
th treatment, Rj is the period effect for
the jth period, Ck is the sheep effect for the k
th sheep and εijk is the random error
associated with Yijk. When a significant treatment effect was detected, means were
compared using Tukey-Kramer Multiple Comparison Test. Backward stepwise regression
was performed in which a third order model was tried first, and if not significant the
analysis was repeated with a lower order model until significance was reached. The 95%
confidence intervals were calculated for the slopes of the regression equation.
Significance of differences between first pass utilization and net absorption was assessed
by Student’s t test. Data are presented as least square means ± SEM and differences were
considered significant at P ≤0.05.
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RESULTS
Sheep. Sheep consumed their feed allowances with no refusals throughout the
experiment and over the period of experimentation (55 days) sheep gained ~75 g/d. The
MDV measurements for one sheep were omitted due to catheter tip misalignment noted
post-mortem, and for another sheep the PDV data were omitted for the last two treatment
periods (35 and 105 g casein/d) due to PDV catheter blockage.
Plasma concentrations. Casein infusion significantly increased (P < 0.05) arterial
concentrations (Table 3.2) of the BCAA, methionine, phenylalanine and proline whereas
glycine concentration decreased (P < 0.05). Plasma urea also increased (P < 0.001) with
level of casein infusion, with values doubling between the Control and the 105 g/d casein
infusion level.
MDV net fluxes. Casein infusion significantly (P < 0.05) increased the net
appearance in the MDV of all the essential AA (Table 3.3), except for tryptophan.
Amongst the non-essential AAs, the net appearances of only alanine (P < 0.05) and
proline (P < 0.001) increased with casein infusion level. The incremental efficiency of
absorption (∆ net absorption ÷ ∆ casein-AA infusion) was computed based on the slope
of regressing net AA absorption against the casein-AA infusion rate for that AA (see Fig.
3.1). The 95% confidence intervals were generated to test for unity, i.e. a slope of 1
equating to 100% recovery of the infused AA. Net MDV absorption (Table 3.4) of all
essential and non-essential AAs, except for glutamate and glutamine, was linearly (P <
0.05) related to their casein-AA infusion rates. The incremental efficiency of absorption
across the MDV fell within a narrow range (0.87 to 1.05) for all essential AA, excluding
tryptophan. For the non-essential AA, values ranged from 0.46 for aspartate to 1.79 for
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alanine. Because of the wide confidence intervals associated with each AA measurement,
however, there was no statistical basis to suggest anything other than that net absorption
across the MDV (small intestines) accounted for 100% of the additional casein-AA
infused.
PDV net fluxes. Net PDV absorption (Table 3.5) of leucine, isoleucine,
methionine, phenylalanine, alanine, proline, and aspartate increased (P < 0.05) in a linear
relationship with their casein-AA infusion rates. Based on the regression slopes, the
incremental efficiency of absorption (Table 3.6) across the PDV ranged from 0.60 for
valine and isoleucine to 0.93 for phenylalanine, with a high of 1.58 for alanine. For the
BCAA, the upper confidence limits were significantly less than 1 (P < 0.05), indicating
that less than 100% of the additional supplies of these AAs was recovered in blood by the
PDV.
For the MDV and PDV, net removal of urea from plasma was not affected by
casein infusion, although numerically the values were higher. The correlation of urea
removal with plasma urea concentration was significant for the MDV (P = 0.0379, r =
0.90) and PDV (P = 0.0124, r = 0.93).
Leucine metabolism. Rate of casein infusion increased (P < 0.01) systemic and
whole body leucine Ra (Table 3.7). As a proportion of whole body leucine Ra, the MDV
accounted for 0.16 (± 0.059) whereas casein infusion increased the proportion (0.33 to
0.60 ± 0.060, P < 0.033) of whole body leucine Ra partition to the PDV. Although there
net absorption of leucine by the PDV increased with casein infusion, there was also
increased (P < 0.05) first-pass arterial utilization of leucine by the PDV. For the MDV,
net absorption of leucine increased with casein infusion, but there was no change in the
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rate of first-pass arterial utilization. Fractional first-pass intestinal utilization was
computed from PDV, rather than MDV, flux measurements to avoid introduction of
errors due to site of luminal tracer infusion and location of the downstream MDV
sampling catheter. Fractional first-pass intestinal utilization of leucine was higher
(Student’s t test, P < 0.05) than fractional first-pass arterial utilization, but neither was
altered by casein infusion.
Glucose metabolism. Plasma glucose concentration increased (P < 0.05) with
casein infusion rate (Table 3.8) whereas plasma glucose Ra remained unchanged. The
relationship of glucose Ra and casein infusion rate was linear (P < 0.05, R
2 = 0.76), with
daily glucose Ra increasing by 0.188 g glucose/g casein infused. Intestinal casein infusion
did not alter the amount and proportion of whole body glucose Ra partitioned to the PDV.
The PDV accounted for ~0.38 of whole body glucose Ra whereas the MDV accounted for
a smaller but increasing (0.11 to 0.24) proportion in response to casein infusion. Due to
the higher rates of first-pass arterial utilization of plasma glucose, the net balances of
glucose across the PDV and MDV were negative (i.e. arterial utilization > net absorption)
and these were not significantly affected by casein infusion. First-pass arterial utilization
of glucose by the PDV (Student’s t test, P < 0.001) and MDV (Student’s t test, P <
0.0011) both exceeded net glucose removal, indicating that glucose was absorbed from
the small intestines only to be removed on second-pass from blood.
DISCUSSION
Despite the numerous studies in the literature, there remains a lack of
information in ruminants and other farm species regarding the patterns of AA utilized by
the GIT and whether this pattern of use fluctuates or remains unchanged with intestinal
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protein supply. In part, the availability of such information has been limited by analytical
and technical constraints of existing methodologies. Therefore, to address the questions
we posed, the methods we employed for measurement of blood flow and substrate
concentrations needed to be sufficiently accurate and sensitive for detection of
biologically and statistically significant changes in the flux of AAs, urea and glucose by
the GIT. Herein, gravimetric (i.e. weighing) procedures and isotope dilution with GC-MS
was employed to quantify plasma AA, urea and glucose concentrations. Based on the
isotope dilution technique, the coefficient of determination was 0.56-3.93% for individual
AAs, 0.12% for urea and 0.33% for glucose. By contrast, conventional AA analyzers may
reach a precision of only 1-4% (Qureshi and Qureshi 1989), and this variance is further
propagated when measurements of both arterial and venous concentrations are combined
for detection of often small (2-15 µmol/L) arterio-venous differences across tissue beds
(19), such as in the present study.
It was also important that our measurements of GIT metabolism were made over a
wide range of intestinal protein supplies, spanning from marginal to above estimated MP
requirements for maintenance and growth for sheep of this body weight. This was
achieved by infusion of casein into the duodenum at four levels (0, 35, 70 and 105 g/d).
The highest level of protein supply was predicted to raise total protein supply (diet +
casein infusion) to 110% of the MP supply required to support gain of 300 g/d for sheep
of this size (AFRC, 1992). Furthermore, to acquire a more representative estimate of the
efficiency of AA absorption, net fluxes for each AA were plotted against their respective
casein-AA infusion rates (Fig. 3.1 and Tables 3.4 and 3.6). Regression slopes were
derived that are analogous to the net efficiency of absorption above the basal level of
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protein intake in this study. Confidence intervals (95%) were then computed from the
slope relationships and tests against unity (i.e. 100%) were performed for each AA.
There are three observations from the slopes of the regression analysis that we
wish to highlight. First, the net absorption data for each essential AA best fit a linear
relationship (P < 0.005; Fig. 3.1 and Tables 3.5 and 3.6) in response to casein infusion.
We had hypothesized that because the level of metabolizable protein intake (~75 g/d) of
the basal ration was low relative to growth requirements, net AA requirements of the GIT
may not have been met and, in consequence, net absorption would not increased until
perhaps the 70 g casein infusion level. Even with the limited observations in this study
(see Fig. 3.1), there appears to be no indication of an inflection in net absorption, but this
will need to be further confirmed at lower protein intakes and with a larger number of
observations.
Second, the 95% confidence intervals of the slopes indicated that essential AA
absorption by the MDV (small intestines) was effectively 100% (i.e. slope = 1) whereas
absorption of the BCAA by the PDV was significantly less than 100% (i.e. slope < 1).
Also approaching significance were the slopes for threonine (slope 0.75, 95% confidence
interval 0.36 to 1.10) and lysine (slope 0.78, 95% confidence interval 0.55 to 1.05) for the
PDV. We interpret these data as demonstration that the small intestines (MDV) were in
net balance with respect to essential AA utilization, irrespective of the rate of intestinal
protein supplies above the maintenance requirement. The net efficiency of absorption of
the BCAA by the PDV was less than 100% (slope ranges: 0.60-0.66, 95% confidence
interval 0.31 to 0.91) across the protein infusion levels with, in consequence, greater net
metabolism (e.g. lost as protein into the GIT or catabolized) of the BCAA as intestinal
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protein supply increased. In fact, for leucine, as representative of the BCAA, the majority
of the increased use by the GIT occurred from the arterial blood supply (Table 3.7),
mainly by the non-MDV tissues (i.e. rumen, hind-gut). MacRae et al. (1997a, 1997b)
made similar observations in sheep (~35 kg body weight) that were fed alfalfa pellets
(15.6% crude protein) at two levels of intake (maintenance vs. 1.5× maintenance). In that
report, recoveries of the essential AA in the MDV approximated to 100% (mean 106%,
range 74-131%) whereas recoveries by the PDV were significantly less (mean 69%,
range 45-96%) than the disappearance of the AAs from the small intestines (duodenum to
ileum).
Thirdly, for both glutamate and glutamine, net absorption by the MDV and PDV
were far less than their intestinal supplies and net absorption were not increased by casein
infusion. We find it of interest that the BCAA, glutamate and glutamine were utilized by
the whole GIT in greater amounts as the supply of protein to the small intestines
increased. The primary fates of AAs utilized by the GIT are catabolism and incorporation
into constitutive and secretory proteins (Stoll et al., 1998, Stoll et al., 1999). Except for
the threonine-rich mucoproteins (van Klinken et al., 1995), the AA composition of GIT
protein is not likely to fluctuate. In this respect, we consider it unlikely that the higher
removals of the BCAA, glutamate and glutamine by the GIT relates to their increased
incorporation into GIT proteins (and endogenous losses). If the additional removal of
these AAs had been directed towards GIT protein synthesis, we should have also
observed a corresponding increase in the net removal of other essential AAs, which we
did not observe. The more likely explanation is that these AAs were catabolized either by
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luminal microbes or by the gut tissues either from the luminal, arterial or both aspects of
the GIT.
The BCAA have been shown to be oxidized by the GIT of ruminants (Lobley et
al., 2003) and considerable evidence indicates extensive catabolism of glutamate and
glutamine by the GIT of ruminants and monogastric species (Caton et al., 2001; Reynolds
et al., 1991; Stoll et al., 1999; Bos et al., 2003; van der Schoor et al., 2001; Windemueller
and Spaeth, 1980). For leucine and glutamate, their oxidation by the GIT fluctuates in
direct relation to intestinal protein supply (dairy cattle: Lapierre et al., 2002; piglets: van
der Schoor et al., 2001). To date, it remains unresolved whether catabolism of AA occurs
directly by the GIT tissues or by microbes in the intestinal lumen. The present data
indicate nearly complete metabolism of glutamate and glutamine by the MDV tissue
(small intestines), but it was not possible herein to determine the extent of luminal vs.
arterial use. However, based on out leucine kinetic data, most of the increased use of
leucine by the GIT occurred from the arterial supply in response to casein infusion.
Therefore, we suggest that the GIT tissues, but not luminal microbes, were responsible
for metabolism of the BCAA.
Numerous studies in rats (see Windmueller et al., 1980) and piglets (Stoll et al.,
1999: see also Wu et al., 1998), under conditions of adequate food intake, have shown
that AAs are the major (50-70%) substrates contributing to oxidative energy generation
by the intestinal mucosa. By contrast, glucose contributes relatively less (30-40%, Wolf
et al., 1972). Similar information is not complete for ruminant animals, and to date
investigations in vivo have been limited to glutamate and glutamine (Reeds et al., 1998),
leucine (MacRae et al., 1999, Yu et al., 2000) and lysine, methionine and phenylalanine
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(Lobley et al., 2003). Given that the GIT of the sheep appears to metabolize greater
amounts of the BCAA, glutamate and glutamine as protein supply is increased, it was
logical to consider whether metabolism of other nutrients would be reciprocally reduced,
namely glucose. The majority of glucose supplied to the ruminant GIT is from the arterial
blood, and so it is commonly observed that net balance of glucose across the MDV and
PDV is negative. There is, of course, some glucose available to the small intestinal lumen
from dietary starch escaping the rumen and from bacterial polysaccharides (Lou et al.,
1997). It is apparent from the comparison of unidirectional and net removals of glucose
(Table 3.8) that glucose was presented to the small intestinal lumen and absorbed into the
MDV and PDV blood drainages (i.e. unidirectional > net removal).
Net removal and first-pass arterial utilization of glucose by the GIT remained
constant across the levels of casein infusion, suggesting that glucose use by the PDV was
not spared by the additional protein supply. This is perhaps not surprising for two
reasons. First, Van der Schoor et al., (2001) observed that glucose oxidation by the PDV
of piglets remained the same at two levels of protein intake (9.6 vs. 21.6 g/(kg • d)). And,
second, catabolism of BCAA carbon skeletons occurs mainly via acetyl-CoA, and for
these AA to spare glucose from complete catabolism necessitates that glucose is also
metabolized via this route. In a study conducted with isolated sheep rumen epithelial and
small intestinal mucosal cells (Bequette et al., 2004), we observed that glucose
contributed to only 1-5% of acetyl- CoA flux, despite the fact that glucose made a
significant contribution to pyruvate flux (8-38%). In this connection, it would not be
expected that increased metabolism of the BCAA by the GIT would lead to sparing of
glucose from complete catabolism. On the other hand, we have shown that sheep rumen
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and intestinal cells partially catabolize glucose to pyruvate, and thence to alanine
(Bequette et al., 2004), and that net production of alanine by intestinal cells is increased
in the presence of glucose (Oba et al., 2005). In this connection, the high and increased
net release of alanine by the PDV with casein infusion may reflect greater partition of
glucose towards alanine synthesis and release.
In summary, AA and glucose metabolism by the MDV and PDV was examined in
growing sheep in response to incremental increases in protein supply to the small
intestines that spanned the range of metabolizable protein supplies from marginal to well
above requirements for maintenance and growth. The efficiency of absorption above
maintenance of all the essential AAs, except the BCAA, was effectively 100% and this
remained fixed at levels of protein supply above maintenance. By contrast, the efficiency
of absorption the BCAA, glutamate and glutamine were less than 100%, and for
glutamate and glutamine high rates of net metabolized by the GIT were maintained even
at upper levels of intestinal protein supply. Despite the excess metabolism of these AAs,
glucose utilization by the GIT was not altered, and therefore not spared by AA supply.
The basis for the greater metabolism the BCAA, glutamate and glutamine with increased
intestinal protein supply remains uncertain. In practical terms, the nearly complete
catabolism of these non-essential AAs and to some extent aspartate by the GIT
necessitates that they be synthesized de novo from carbon skeletons and nitrogen that
likely derive from absorbed essential AA.
64
TABLE 3.1 
Ingredients and nutrient composition of the experimental diet1
g/kg diet
Ingredient
Alfalfa meal 17% 301
Beet pulp, dried 200
Wheat straw 467
Ammonium chloride 5





Acid detergent fiber 358
Neutral detergent fiber 521
Starch 39
Crude fat 24
Total digestible nutrients 610
Net energy for maintenance, MJ/kg 5.44
Net energy for gain, MJ/kg 3.23
1 As-fed.
2 Shepherd’s Pride®, provided per kg premix: calcium, 220 g; salt 160 g; sulfur, 31 g;
phosphorus, 30 g; magnesium, 27 g; potassium, 24 g; iron 1,820 mg; zinc 2,700 mg;
manganese 240 mg ; iodine 40 mg; cobalt 35 mg ; selenium 24 mg; vitamin A, 682,799
IU; vitamin D, 137,574 IU; vitamin E, 1,774 IU. (Renaissance Nutrition, Inc. Roaring
Spring, PA 16673).
3 XP-4®, sodium acid pyrophosphate and monosodium phosphate anhydrous,
provided per kg premix: phosphorus, 260 g; sodium, 193 g. (Astaris LLC, 622 Emerson
road, St. Louis, MO 63141).
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TABLE 3.2 
Plasma arterial concentrations (µmol/kg plasma) of amino acids and urea in sheep
infused with increments (0, 35, 70 and 105 g/d) of casein into the duodenum1
1 Values are least-square treatment means, n = 16. abc Means with different
superscripts within a row are significantly different from one another (P < 0.05).
Abbreviations: SEM, pooled standard error of the means; NS, not significant (P > 0.05).
Casein infusion (g/d)
0 35 70 105 SEM P-value
Essential AA
Valine 204c 296b 370b 450a 18.6 0.0001
Leucine 153c 209b 244ab 281a 13.0 0.0007
Isoleucine 89b 118a 134a 139a 6.4 0.0002
Methionine 24b 33ab 38ab 40a 3.6 0.0431
Threonine 95 134 140 109 21.2 NS
Phenylalanine 48b 57b 61ab 72a 3.5 0.0044
Lysine 155 202 194 175 18.3 NS
Histidine 56 75 71 69 6.7 NS
Tryptophan 40 55 59 90 19.0 NS
Non-essential AA
Alanine 169 170 144 131 13.4 NS
Glycine 533a 427b 361bc 313c 37.2 0.0003
Proline 84c 136b 142b 192a 8.6 0.0001
Serine 55 62 61 54 11.2 NS
Aspartate 16 20 17 17 2.4 NS
Glutamate 120 133 109 118 6.4 NS
Glutamine 275 284 259 277 20.2 NS
Urea, mmol/kg 6.35c 8.52b 10.36b 13.52a 0.604 0.0001
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TABLE 3.3 
Plasma flow and net absorption of amino acids across the mesenteric-drained viscera of
sheep infused with increments (0, 35, 70 and 105 g/d) of casein into the duodenum.1
Casein infusion (g/d)




kg/(kg BW • h) 1.082 1.116 1.373 1.567 0.2330 NS
Net absorption, µmol/(kg BW • h)
Essential AA
Valine 43b 45b 95a 87a 11.4 0.0044
Leucine 51b 61b 129a 116a 10.5 0.0008
Isoleucine 35b 39b 74a 70a 7.0 0.0031
Methionine 13c 15bc 30ab 32a 3.3 0.0078
Threonine 35b 42ab 70a 67ab 9.0 0.0249
Phenylalanine 30b 33b 64a 61a 6.4 0.0051
Lysine 48b 52b 101a 97a 10.1 0.0043
Histidine 14b 14b 23ab 34a 5.8 0.0158
Tryptophan 7 2 25 33 6.9 NS
Non-essential AA
Alanine 69b 77ab 129a 125ab 12.8 0.0220
Glycine 61 66 88 83 11.1 NS
Proline 31b 46b 102a 105a 7.7 0.0005
Serine 55 55 95 94 13.9 NS
Aspartate 3 9 11 14 3.4 NS
Glutamate 20 24 40 38 9.7 NS
Glutamine -3 -4 45 25 24.1 NS
Urea -175 -204 -373 -361 68.7 NS
1 Values are least-square treatment means, n = 14. Positive values denote net release
(absorption into blood) and negative values denote net removal from blood. abc Means
with different superscripts within a row are significantly different from one another (P <




Plasma flow and net absorption of amino acids across the portal drained viscera of sheep
infused with increments (0, 35, 70 and 105 g/d) of casein into the duodenum1
Casein infusion (g/d)
0 35 70 105 SEM P-value
Plasma flow,
kg/(kg BW • h) 2.795 2.515 2.488 3.055 0.3065 NS
Net absorption, µmol/(kg BW • h)
Essential AA
Valine 32 39 58 69 9.7 NS
Leucine 46c 60bc 86ab 95a 7.8 0.0043
Isoleucine 27c 35bc 49ab 56a 4.4 0.0035
Methionine 11c 15bc 27ab 30a 3.1 0.0043
Threonine 25 32 43 56 7.5 NS
Phenylalanine 31b 38b 51ab 62a 5.3 0.0113
Lysine 41 52 72 85 9.7 NS
Histidine 14 14 19 29 3.5 NS
Tryptophan 7 1 9 11 4.2 NS
Non-essential AA
Alanine 61c 80bc 101ab 119a 7.8 0.0020
Glycine 39 56 47 75 9.7 NS
Proline 24c 42bc 77ab 93a 9.1 0.0010
Serine 61 60 87 81 22.9 NS
Aspartate -2b 4ab 9ab 22a 7.1 0.0380
Glutamate 6 21 34 23 12.5 NS
Glutamine -6 10 73 13 44.1 NS
Urea -587 -625 -671 -1072 124.7 NS
1 Values are least-square treatment means, n = 14. Positive values denote net release
(absorption into blood) and negative values denote net removal from blood. abc Means
with different superscripts within a row are significantly different from one another (P <




Linear mixed-effect model predictions of the intercept, slope and 95% confidence
intervals describing the relationship between net mesenteric-drained viscera absorption
(µmol/(kg BW • h) of amino acids and the rate of casein-amino acid infusion (0, 35, 70










Valine 39 10.7 0.87 0.223 0.0045 0.69 (0.55, 1.21)
Leucine 50 11.4 1.01 0.233 0.0014 0.65 (0.73, 1.28)
Isoleucine 33 6.3 0.88 0.191 0.0017 0.71 (0.43, 1.30)
Methionine 12 2.7 1.00 0.198 0.0005 0.72 (-0.02, 1.94)
Threonine 36 8.1 0.89 0.239 0.0073 0.73 (0.36, 1.44)
Phenylalani
ne 29 6.1 1.05 0.267 0.0041 0.65 (0.41, 1.66)
Lysine 45 9.5 0.99 0.236 0.0029 0.68 (0.62, 1.35)
Histidine 11 5.6 1.00 0.231 0.0024 0.81 (-0.10, 2.01)
Tryptophan 1 5.7 4.74 1.352 0.0056 0.55 (1.39, 7.84)
Non-essential AA
Alanine 66 10.7 1.79 0.449 0.0025 0.56 (0.91, 2.63)
Glycine 62 10.2 0.96 0.391 0.0388 0.26 (-0.26, 2.23)
Proline 29 8.1 0.77 0.121 0.0001 0.78 (0.46, 1.07)
Serine 51 12.1 1.06 0.397 0.0280 0.42 (0.30, 1.80)
Aspartate 4 3.2 0.46 0.098 0.0051 0.29 (-0.94, 1.86)
Glutamate 20 7.5 0.23 0.131 NS 0.21 (-0.14, 0.58)
Glutamine -2 19.8 0.47 0.418 NS 0.18 (0.02, 0.86)
1 Values were derived from the model: bxay +=ˆ , where x is the casein-amino acid
infusion rate in µmol/(kg BW • h), a the intercept and b the slope of the regression (n =
12). Abbreviations: SEa, standard error of the intercept (a) estimate; SEb, standard error
of the slope (b) estimate; NS, Not significant (P > 0.05).
2 Probability that the slope estimate = 0.
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TABLE 3.6 
Linear mixed-effect model predictions of the intercept, slope and 95% confidence
intervals describing the relationship between net portal-drained viscera absorption
(µmol/(kg BW • h) of amino acids and the rate of casein-amino acid infusion (0, 35, 70









Valine 30 7.4 0.60 0.159 0.0044 0.66 (0.37, 0.82)
Leucine 46 5.7 0.66 0.126 0.0002 0.69 (0.48, 0.86)
Isoleucine 27 3.6 0.60 0.109 0.0004 0.76 (0.31, 0.91)
Methionine 11 2.5 0.91 0.197 0.0010 0.66 (0.29, 1.64)
Threonine 24 6.1 0.75 0.186 0.0029 0.71 (0.36, 1.10)
Phenylalanine 29 4.0 0.93 0.175 0.0004 0.77 (0.55, 1.40)
Lysine 39 6.7 0.78 0.188 0.0021 0.62 (0.55, 1.05)
Histidine 12 2.7 0.67 0.225 0.0109 0.43 (0.02, 1.46)
Tryptophan 4 3.8 0.77 0.701 NS 0.56 (-1.26, 3.16)
Non-essential AA
Alanine 60 5.2 1.58 0.223 <0.0001 0.82 (0.26, 2.94)
Glycine 39 7.7 1.20 0.484 0.0347 0.45 (-0.72, 3.17)
Proline 23 6.8 0.67 0.108 <0.0001 0.76 (0.20, 1.15)
Serine 58 18.4 0.61 0.532 NS 0.55 (-0.51, 1.82)
Aspartate -3 7.2 0.95 0.161 0.0011 0.95 (-1.10, 3.27)
Glutamate 10 9.2 0.24 0.172 NS 0.14 (-0.31, 0.80)
Glutamine -1 35.8 0.58 0.648 NS 0.43 (-0.17, 1.14)
1 Values were derived from the model: bxay +=ˆ , where x is the casein-amino acid
infusion rate in µmol/(kg BW • h), a the intercept and b the slope of the regression (n =
12). Abbreviations: SEa, standard error of the intercept (a) estimate; SEb, standard error
of the slope (b) estimate; NS, not significant (P > 0.05).
2 Probability that the slope estimate = 0.
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TABLE 3.7 
Whole body and gastrointestinal tract fluxes of leucine in sheep infused with increments
of casein (0, 35, 70 and 105 g/d) into the duodenum1
Casein infusion (g/d)
0 35 70 105 SEM P-value
Leucine Ra
Systemic Ra (A) 163
c 187bc 216ab 244a 14.9 0.0075
Whole body Ra (B) 236
b 251b 286ab 318a 19.6 0.0111
First-pass splanchnic
Utilization (B – A)




0.30 0.26 0.25 0.24 0.029 NS3
Portal-drained viscera metabolism
Net absorption 46c 60bc 86ab 95a 7.8 0.0043
First-pass arterial
utilization
53b 62b 70b 146a 7.7 0.0001
Proportion of whole body
Ra 
0.33b 0.34b 0.33ab 0.60a 0.060 0.033
Fractional first-pass
arterial utilization
0.13 0.12 0.11 0.16 0.023 NS
Fractional first-pass
intestinal utilization
0.32 0.32 0.20 0.27 0.060 NS
Mesenteric-drained viscera metabolism
Net absorption 51b 61b 129a 116a 10.5 0.0008
First-pass arterial
utilization
24 30 36 36 11.1 NS
Proportion of whole
body Ra
0.15 0.17 0.17 0.15 0.059 NS
Fractional first-pass
arterial utilization
0.16 0.13 0.10 0.10 0.028 NS
1 Values are in units of µmol/(kg BW • h) unless otherwise indicated. Values are
least-square treatment means for whole body (n =16), mesenteric-drained viscera (n =12)
and portal drained viscera (n =14) fluxes. Positive values denote net release (absorption
into blood) and negative values denote net removal from blood. a-c Means within a row
not sharing a common superscript differ significantly (P < 0.05). Abbreviations: Ra, rate
of appearance; SEM, pooled standard error of the mean; NS, not significant (P > 0.05).
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TABLE 3.8
Whole body and gastrointestinal tract metabolism of glucose in sheep infused with
increments of casein (0, 35, 70 and 105 g/d) into the duodenum.1
Casein infusion (g/d)
0 35 70 105 SEM P-value
Arterial concentration,
(µmol/kg) 4.249b 4.283b 4.540a 4.567a 0.1086 0.0103
Plasma Ra 690 730 783 814 49.5 NS
Portal-drained viscera metabolism
Net absorption -110 -111 -128 -216 49.8 NS
First-pass arterial
utilization 255 247 302 322 76.0 NS
Proportion of plasma Ra 0.37 0.35 0.41 0.38 0.101 NS
Fractional arterial
utilization 0.02 0.02 0.03 0.02 0.007 NS
Mesenteric-drained viscera metabolism
Net absorption -25 -66 -37 -70 23.303 NS
First-pass arterial
utilization 83 143 187 119 31.495 NS
Proportion of plasma Ra 0.11
b 0.21ab 0.24a 0.14ab 0.041 0.022
Fractional arterial
utilization 0.02 0.03 0.03 0.02 0.005 NS
1 Values are in units of µmol/(kg BW • h) unless otherwise indicated. Values are
least-square treatment means for whole body (n =16), mesenteric-drained viscera (n
=12) and portal drained viscera (n =14) fluxes. Positive values denote net release
(absorption into blood) and negative values denote net removal from blood. ab Means
within a row not sharing a common superscript differ significantly (P < 0.05).
Abbreviations: Ra, rate of appearance; SEM, pooled standard error of the mean; NS,
not significant (P > 0.05).
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Figure 3.1. Plots of mesenteric (MDV; n = 12) and portal (PDV; n = 14) net
absorption rates of leucine (A), lysine (B), histidine (C) and methionine (D) against
their rates of infusion as casein into the duodenum of sheep. (see Tables 3.5 and 3.6
for linear regression analysis).
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CHAPTER 4
METABOLIC PROFILING OF SUBSTRATE METABOLISM IN BEEF
RUMEN EPITHELIAL AND DUODENAL MUCOSAL CELLS




The aim of this study was to determine the flux and contributions to overall
Krebs cycle metabolism of primary substrates normally available to the rumen and
small intestinal tissues. An additional aim was to determine whether the type of diet
fed to steers altered the use and selection of these substrates for metabolism. To meet
these aims, rumen epithelial (REC) and duodenal mucosal cells (DMC) were isolated
from two groups of Angus bulls (5 per group, 391 ± 34 kg) that were fed either a high
forage (75% Orchard grass silage) or a high concentrate (75% concentrate mix) diet
for 4 weeks prior to slaughter at which time cells were isolated for incubations. Cell
incubations were conducted with media containing all amino acids (AAs), glucose,
and the three primary short chain fatty acids (acetate, propionate and butyrate;
SCFAs) produced in the rumen. [1-13C] or [U-13C] tracer forms of glucose, acetate,
propionate, butyrate, glutamate, glutamine, valine and leucine were individually
added to triplicate incubations to determine the extent and routes of their metabolism
in the Krebs cycle of REC and DMC. Our results indicated that glucose contributed
25% of lactate flux in REC from bulls fed high concentrate and in DMC from bulls
fed both diets. By contrast, in REC form bulls fed the high forage diet glucose
contributed only 12% of lactate flux. Furthermore, the flux of leucine and valine to
ketoisocaproic and ketoisovaleric acid increased with leucine (17-63%) and valine
(19-82%) supplies, but neither entered Krebs cycle intermediates. Glutamate was the
largest contributor to α-ketoglutarate flux and this contribution increased (9-41%)
with glutamate supply. By contrast α-ketoglutarate flux from glutamine did not
exceed 3%. These data suggest that the partial catabolism of glucose to lactate and
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possibly alanine may play a role in preserving 3-carbon units from glucose for
gluconeogenesis. Furthermore, increasing the supply of glutamate to REC and DMC
increase the flux of Krebs cycle intermediates from glutamate, thereby reducing the
entry of other substrates entering at or beyond α-ketoglutarate. Glutamine catabolism
by GIT cells has been previously demonstrated, but in the current study glutamine
entry to the Krebs cycle was limited. Therefore, glutamine catabolic pathway(s) merit
further investigation
Key words: gastrointestinal, amino acids, glucose, short chain fatty acids
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INTRODUCTION
In ruminants, the gastrointestinal tract (GIT) represents less than 10% of
empty body weight (McLeod and Baldwin, 2000) yet its metabolic activity accounts
for 25 to 35% of whole body protein synthesis (Lobley et al., 1994) and 30% of
whole body oxygen consumption (Burrin et al., 1989). Furthermore, studies have
shown that, across all species, metabolism by the GIT is the single largest fate of
AAs, glucose and several short chain fatty acids (SCFA). Evidence in the rat and pig
suggests that, in addition to AA metabolism for protein synthesis, the GIT also
catabolizes essential (EAAs) and non essential (NEAAs) AAs for energy production
(Windmueller and Spaeth, 1974, 1978, 1980; Stoll et al., 1998; Stoll et al., 1999; van
Goudoever et al., 2000; van der Schoor et al., 2001). In this respect, the catabolism of
AAs and glucose by the GIT has been shown to be highly correlate with their
availability in the small intestines and in the blood supply (Stoll et al., 1998; Stoll et
al., 1999; van Goudoever et al., 2000; van der Schoor et al., 2001). In ruminants
however, studies that describe the extent that AAs are catabolized for energy
production are scarce.
Studies measuring EAA oxidation by the ruminant GIT have mostly been
carried out using leucine as a tracer (MacRae et al., 1997; Cappelli et al., 1997; Yu et
al., 2000). Diet alterations have been reported to affect EAA oxidation in dairy cows
where increasing the dietary supply of metabolizable protein led to an increase in
leucine oxidation from 16 to 22% of small intestinal utilization (Lapierre et al., 2002).
In this connection, it remains unclear whether this oxidation represents an obligate
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requirement or whether oxidation can be reduced by providing alternative energy
substrates.
Glutamine and glutamate have been shown to contribute to energy production
in isolated rumen epithelial (REC) and duodenal mucosal (DMC) cells (Harmon et
al., 1986; Okine et al., 1995; Oba et al., 2004). In these studies, REC and DMC
incubated in the presence of glucose produced less CO2 from glutamine, however the
presence of glucose did not affect CO2 production from glutamate (Oba et al., 2004).
This metabolic flexibility was also observed for short chain fatty acids (SCFA),
which decreased glutamine and glucose catabolism in REC and DMC when added to
the media (Harmon, 1986; Oba et al., 2004). Combined, these observations seem to
suggest that glutamate catabolism is obligate whereas catabolism of glutamine may
not be obligate and that its catabolism may depend upon the availability of other
complimentary substrates. The results also suggest that glucose and SCFAs can
replace the need for certain AAs to be catabolized, and this raises the question of why
this replacement phenomenon is not common to all AAs.
Glucose removal by the GIT represents a significant (0.30-0.35) proportion of
whole body utilization (Balcells et al., 1995; Cappelli et al., 1997). In some studies
glucose infusion increased AA net absorption across the PDV (Huntington and
Reynolds, 1986). Similarly, SCFAs are also metabolized by GIT tissues and
propionate infusion into the rumen of beef cattle led to an increase in the net
absorption of AA across the GIT (Seal and Parker, 1994; 1996). With both glucose
and propionate, the net flux data seem to suggest that either these substrates replaced
the need to metabolize AA or that other metabolic signals (e.g. insulin) initiated by
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glucose and propionate had regulated (reduced) AA catabolism. If the former is
correct, then the mechanism(s) by which glucose and SCFAs reduce AA catabolism
presumably occurs because these substrates are metabolized via the Krebs cycle at
pyruvate, acetyl-CoA and succinyl-CoA, points of entry that nearly all AAs must
eventually flow through for their catabolism.
Much remains to be elucidated about the regulation of substrate catabolism by
the GIT of ruminants. Our hypothesis was that REC and DMC possesses metabolic
flexibility in substrate selection for catabolism by the Krebs cycle and that this
metabolism is dependent upon diet conditions and the mix of substrates availability to
the tissues. The objectives of this study were to determine the routes and extents of
metabolism of acetate, butyrate, propionate, glucose, glutamate, glutamine, leucine
and valine by REC and DMC in vitro. Metabolic measurements were made by
incubating isolated GIT cells in media containing [1-13C] or [U-13C] tracer forms of
the latter substrates and by use of mass spectrometry and 13C-isotopomer distribution
in the Krebs cycle and keto-acid intermediates, their routes of catabolism were
determined.
MATERIALS AND METHODS
Animals and diets. The experimental protocol was approved by the Beltsville Area
Animal Care and Use Committee at the Beltsville Agricultural Research Center and
the Institutional Animal Care and Use Committee at the University of Maryland.
Twelve Angus bulls were housed in individual stalls and adapted to their environment
and fed orchard grass silage for 1 wk prior to the initiation of the experiment.
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Animals were divided into two groups based on body weight so that the
average weight per group was 391 ± 34 kg. Two dietary treatments were randomly
assigned to the groups in a completely randomized design. The two diets (Table 4.1),
comprised of high forage (HF; 75% orchard grass silage and 25% concentrate) or
high concentrate (HC; 25% orchard grass silage and 75% concentrate), were fed to
meet the requirements (NRC, 2000) for dry matter intake and energy to support 0.5
kg body weight gain per d.
Fresh water was available ad libitum using automatic waterers and feed was
offered daily in the morning. Feed refusals were weighed. The bulls were weighed on
weekly basis throughout the duration of the experiment, and feed intake adjusted
accordingly.
Isolation of REC and DMC. Bulls were stunned with a captive-bolt gun and
immediately exsanguinated. The gastrointestinal tract was removed from the
abdominal cavity within 15 min. A 15×30 cm piece of rumen wall was taken from
the cranial sac. The piece was rinsed with warm tap water to remove feed particle and
debris followed by warm isotonic buffer2 (KRB-HEPES). The epithelial layers were
stripped off the musculature, cut into 2×5 cm strips and transported to the lab in
isolated containers containing trypsin/CaCl2 (5%; 0.016%) in warm KRB-HEPES.
Rumen tissues were allowed to digest in a forced-air orbital shaker (Model
3527 LabLine Instruments, Melrose Park, IL) at 37°C for 30 min. Following the first
digestion cycle, epithelial tissues were filtered through a 1000-µm polypropylene
mesh (Spectra/Mesh, Spectrum Laboratory Products, Los Angeles, CA) and the
2 Krebs-Ringer salts, plus 25 mM HEPES, pH 7.4, 37oC, freshly aerated with with O2:CO2 (95:5%).
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filtrate was discarded. The tissues were redigested in fresh trypsin/CaCl2 (5%;
0.016%) in KRB-HEPES for two more cycles. After each subsequent digestion the
solution was sequentially filtered through a 1000-µm and a 300-µm polypropylene
meshes. The filtrates, recovered from the second and third cycles, were centrifuged
(Centra-MP4R, International Equipment Company, Neeham Heights, MA) at 60×g
for 6 min. The supernatant containing the enzyme and cell debris was discarded and
the cell pellet resuspended in warm KRB-HEPES that contains no enzyme for two
wash cycles after which the cell pellets were combined and suspended in a minimal
volume of buffer to allow for cell concentration adjustments. Cell yield and viability
were assessed using trypan blue dye exclusion method (Baldwin and McLeod, 2000).
Duodenal mucosal cells were collected from a segment taken 1 to 2 m distal to
the pyloric sphincter. The duodenal segment was emptied of digesta, rinsed with
warm tap water followed by rinsing with KRB-HEPES and cut longitudinally.
Mucosa was scraped off the underlining musculature using a glass microscope slide
and minced to 2×5 mm pieces. Scraped duodenal mucosa were transported to the lab
in isolated containers containing collagenase/dispase I/CaCl2 (90CDU
3/ml; 0.6U4/ml;
0.14mg/ml) dissolved in warm KRB-HEPES. Cell isolation was done in a fashion
similar to rumen epithelia with some modifications; mucosa was digested for 45min
in a forced-air orbital shaker at 37°C followed by a sequential filtration through a
1000-µm and a 300-µm polypropylene mesh. Subsequent centrifugation, washing
3 CDU: collagenase digestion unit. One collagen digestion unit liberates peptides from collagen
equivalent in ninhydrin color to 1.0 µmole of leucine in 5 hr at pH 7.4 at 37 °C in the presence of
calcium ions.
4 One unit is the enzyme activity which liberates under assay conditions (37° C, casein as substrate, pH
7.5) within 1 min Folin-positive amino acids and peptides corresponding to 1 µmol tyrosine.
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with KRB-HEPES to remove enzymes and determination of cell yield and viability
was done as described for REC.
Incubations. Incubations were performed in 25-ml Erlenmeyer flasks







13C5]glutamine plus KRB-HEPES and water. Labeled substrates
were added at a final concentration of 0.25, 0.5, 1 or 2.5 times the basal concentration
(Table 4.3) except for the volatile fatty acids in the rumen cell incubation media,
where the concentration reflected those found in rumen fluid. All incubations were
run in triplicates.
Incubation flasks were gassed for 20 s with O2:CO2 (95:5%) and incubation
initiated by the addition of 0.5ml cell suspension to the incubation flask. After the
addition of cells to the media, flasks were sealed with a rubber serum cap, and placed
in a reciprocal water bath (Precision Model 50, Jouan, Cedex, France) set at 37°C for
90min. Incubations were terminated by the addition of 0.2 mL perchloric acid (70%
w/w) followed by neutralization with 0.4 ml potassium carbonate (5.8 mol/ L). Flask
contents were transferred to borosilicate tubes and centrifuged at 2,500 × g for 10
min, and the supernatant decanted to clean tubes and stored at -20oC for analysis.
Metabolite analysis Isotopic enrichment of Krebs cycle intermediates were
analyzed (Des Rosiers et al., 1995) by gas chromatography-mass spectrometry (GC-
MS) followed by isotopomer distribution analysis (Fernandez et al., 1995). To the
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thawed samples was added sulfosalicylic acid to a final concentration of 10% (w/w)
to precipitate proteins, mixed by vortexing and centrifuged at 4000 rpm for 5 min.
The supernatant was decanted to clean screw-cap tubes, 5 mmol of hydroxylamine-
hydrochloride added and the pH adjusted to 7-8 with 4 mol/L potassium hydroxide.
The samples were sonicated for 15 min with heat and then allowed to react at 65oC
for 1 h on a heating block. Hydrochloric acid (6 mol/L) was used to bring the pH
down to <2 and the solution saturated with NaCl and vortexed for 1 min to precipitate
sulfosalicylic acid. Samples were then extracted twice with 4 ml ethyl acetate for 15
min each time using a multi-tube vortexer. Samples were then centrifuged for 5 min
at 2,500 rpm and the organic phase collected into V-vials. Ethyl acetate was dried
under a stream of N2 gas at 40
oC and 30 µL of N-methyl-N-(tert-
butyldimethylsilyl)trifluoroacetamide (MTBSTFA) + 1% tert-
butyldimethylsilylchlorosilane (DMCS) plus ethyl acetate (50:50) added, capped and
allowed to react for 1 h at 65°C on a heating block.
Krebs cycle intermediates were separated by gas chromatography (HP 6890;
Agilent, Palo Alto, CA) using a fused silica capillary column (HP-5; 30 m × 0.25
mm i.d., 1µm Hewlett-Packard) with helium as carrier gas (1.0 mL/ min).
Chromatography was carried out using a temperature gradient (100 oC for 2 min; 30
oC to 160 oC; 10oC/ min to 250oC/ min). The GCMS (HP 5973N Mass Selective
Detector, Agilent, Palo Alto, CA) was operated in the electron ionization mode, and
selected ion monitoring was performed on the [M-57]+ fragments of the tert-
butyldimethylsilyl TBDMS derivatives from [M] to [M+x], where x is the number of
C atoms in the analyte. Ions (mass-to-charge) monitored were for lactate 261-264,
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pyruvate 274-277, β-hydroxybutyrate 275-278, ketoisovaleric and ketoisocaproic acid
316-322, succinate 289-293, malate 419-423, oxaloacetate 432-436 and α–
ketoglutarate 446-451.
Mass isotopomer distributions were corrected for the difference between
theoretical and measured values using the correlation matrix approach (Fernandez et
al., 1995). Enrichments (MPE) were expressed as tracer-tracee ratios (TTR, % moles
tracer/100 moles tracee). The molar fraction (MF) of 13C-labeled isotopomers was
calculated from enrichments as:




where [M+i] is the enrichment of the 13C-labeled isotopomer, [M] is the enrichment
of the unlabeled isotopomer and ∑ +
1
n
n][M is the sum of all 13C-labeled isotopomers
from 1 to n carbons.
Precursor product relationships (FC; fractional contribution) were calculated
(Des Rosiers et al., 1994; Khairallah et al., 2004) using the general equation:
FCprecursor→product = MFproduct / MFprecursor
The FC of glucose to pyruvate and lactate was calculated using the [M+3]
enrichment in lactate or pyruvate incubated with [13C6]glucose:
FCglucose→pyruvate = [M+3]pyruvate / [M+6]glucose
FCglucose→lactate = [M+3]lactate / [M+6]glucose
When glutamate or glutamine are the only source of 13C then their
contribution to the Krebs cycle could be measured from the [M+5]α-ketoglutarate and
[M+4]succinate malate and oxaloacetate due to the loss of one carbon at α-
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ketoglutarate dehydrogenase. The FC of glutamate and glutamine to Krebs cycle
intermediates was calculated as:
FCglutam(x)→α-ketoglutarate = [M+5]α-ketoglutarate / [M+5]glutam(x)
FC glutam(x)→succinate = [M+4]succinate / [M+5]glutam(x)
FC glutam(x)→malate = [M+4]malate / [M+5]glutam(x)
FC glutam(x)→oxaloacetate = [M+4]oxaloacetate / [M+5]glutam(x)
where glutam(x) represents either glutamate or glutamine.
The FC of leucine and valine to KIC and KIV was calculated as:
FC leucine→KIC = [M+6]KIC / [M+6]leucine
FC valine→KIC = [M+5]KIV / [M+5]valine
Statistical analysis. For all data, ANOVA assumptions were checked prior to
analysis. Data were analyzed by ANOVA for a 3-way factorial design using the
MIXED procedure of SAS (version 8.0, SAS Institute, Cary, NC). The following
linear mixed model was used:
Yijk = µ+ Ti + Sj + Lk + TSij + TLik + SLik + TSLijk + εijk
Where Yijk is the observed value for the ith dietary treatment jth substrate and
kth substrate level, µ is the grand mean, Ti is the treatment effect for the ith treatment,
Sj is the substrate effect for the j
th substrate, TSij TLik SLik and TSLijk are the
interaction effects and ijkε is the random error associated with Yijk. When a
significant effect was detected, means were compared using Tukey-Kramer Multiple
Comparison Test. Data are presented as least square means ± SEM and differences
were considered significant at P ≤0.05.
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RESULTS
The isotopomer distributions of metabolic intermediates at physiologic levels
were statistically analyzed (Figure 4.1, 4.2, 4.3, 4.4, and 4.5). When the enrichment
was significantly different from zero, a further statistical analysis was conducted to
test for concentration effect and for FCprecursor→product.
Substrate contributions to pyruvate and lactate flux. There was a significant
(P<0.05) tissue × level interaction for the fractional contribution of glucose to
pyruvate flux (FCglucose→pyruvate). The FCglucose→pyruvate, averaged across diets and
glucose concentrations, was 1.3% for REC and 4.1% for DMC, and for both tissues
this contribution increased with glucose concentration (P<0.05).
There was a diet × tissue interaction (P<0.05) for the contribution of glucose
to lactate flux (FCglucose→lactate). For REC from bulls fed the high concentrate diet and
for DMC from bulls fed both diets, glucose contributed 25% to lactate flux compared
to 12% in REC form bulls fed the high forage diet.
Metabolism of Valine and Leucine. For REC and DMC, leucine was
deaminated to ketoisocaproic acid (KIC), and KIC enrichment (M+6/M+0) had a
significant (P<0.05) diet × tissue interaction (Table 4.4). The enrichment of KIC
from REC incubations was significantly higher than for DMC from bulls fed the high
concentrate diet. Leucine contributed to 18, 28, 43, and 62% of KIC flux at 0.06,
0.12, 0.24, and 0.60 mmol/L [13C6]leucine, respectively. For both diets, the
contribution of [13C5]valine to ketoisovaleric acid flux (KIV) was higher for REC
(58%) than for DMC (40%) (Table 4.5). The average contribution of [13C5]valine to
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KIV in REC and DMC incubations increased from 25 to 73% at the highest
[13C5]valine concentration (P<0.05).
Substrate contributions to Krebs cycle intermediate fluxes. Catabolism of
glutamate to α-ketoglutarate increased with [13C5]glutamate concentration for both
cell types and the contribution of glutamate to α-ketoglutarate flux was higher
(P<0.05) for REC (31%) than for DMC (12%). For REC, glutamate accounted for a
higher proportion (37% vs. 25%, P < 0.05) of α-ketoglutarate flux when bulls were
fed the high concentrate diet. By contrast, there was no effect of diet on glutamate
deamination by DMC (12%). For both cell types the proportion of α-ketoglutarate
flux derived from glutamine catabolism increased (0.1 to 2.7) with [13C5]glutamine
concentration in incubation media and there were no differences between cell types or
diets (Table 4.7).
The contribution (Table 4.8) of α-ketoglutarate to succinate (5 and 10%) and
to malate (9 and 34%) flux was lower for REC than for DMC (P<0.05). Because the
enrichment in succinate was unexpectedly lower compared to malate (Figure 4.5), it
was not possible to calculate the fractional contribution of succinate to malate.
Instead the fractional contribution of α-ketoglutarate to malate was calculated. The
contribution of α-ketoglutarate to malate flux had a significant diet × tissue
interaction (P<0.05). Also, as the concentration of [13C5]glutamate increased, the
contribution of α-ketoglutarate to malate flux decline (26 to 17%). Diet and glutamate
level had no significant effect on the oxaloacetate formed form malate, however there
was a significant difference between REC and DMC in which 31 and 64% of
oxaloacetate formed from malate (P<0.05).
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DISCUSSION
Although the current knowledge suggests that the high metabolic demand for
AA catabolism by the GIT of ruminants occurs in part towards energy production
(MacRae et al., 1997; Cappelli et al., 1997; Yu et al., 2000; Lapierre et al., 2002;
Lobley et al., 2003), the response of AAs, glucose and SCFA metabolic pathways are
not fully understood. It has been shown that diet and nutrient supply could influence
AA use for energy production (Harmon et al., 1986; Oba et al., 2005). In the current
study, intermediary metabolic pathways of macronutrient use were detailed in REC
and DMC by use of specific 13C-labelled substrates normally available to these tissues
in vivo. We set out to test whether REC and DMC possessed metabolic flexibility for
substrate catabolism. We had hypothesized that flexibility to metabolism certain
substrates and thus the ability of other substrates to spare them from catabolism was
dependent upon their initial point(s) of entry to the Krebs cycle.
The results indicated that REC from bulls fed the high concentrate diet
metabolized more glucose to lactate than those from animals fed a high forage diet,
therefore reducing the contribution of other substrates to lactate production. Previous
reports have shown that adaptation in tissue demand for glucose uptake and
catabolism occurred in response to starch feeding (Harmon, 1986). What was
interesting in the present study was that glucose catabolism did not results in entry of
carbon into the Krebs cycle, and thus most of glucose catabolized by the isolated
REC and DMC cells yielded lactate or possibly alanine (Not determined). Lactate
may represent a salvage mechanism for glucose catabolized in glycolytic pathway.
There is evidence to suggest that the high rate of lactate production in fast growing
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cells such as GIT, immune and cancer cells occurs to support ribose production
through the pentose phosphate pathway (Newsholme et al., 1985). Our data also
suggest that CO2 production form glucose (Harmon, 1986; Okine et al., 1995; Seal
and Parker, 1996) could have occurred in the oxidative arm of the pentose cycle.
There are no data in ruminants that have measure glucose oxidation by the pentose
cycle, however in pig enterocytes glucose oxidation accounted for 90% of CO2
production via the pentose cycle (Wu, 1996). It is possible that a similar mechanism
occurs in ruminants GIT given lack of labeling in Krebs cycle intermediates measured
in our study.
Leucine (17-63%) and valine (19-82%) contribution to ketoisocaproic and
ketoisovaleric acid fluxes increased with increasing concentrations. For KIC, there
was no difference between the proportion of KIC produced from leucine between
REC and DMC. However, no detectable incorporation of leucine carbon into Krebs
cycle intermediates occurred in REC and DMC. Increasing the supply of dietary
metabolizable protein has been reported to increased leucine oxidation from 16 to
22% of GIT utilization in dairy cows (Lapierre et al., 2002), and that KIC production
by the GIT increased with feed intake (Pell et al., 1986; Lapierre et al., 1999).
Furthermore, oxidation of leucine by the GIT of sheep accounted for 12-22% of
arterial sequestration and only a limited amount of leucine was oxidized from the
luminal aspect of the small intestines of sheep (0 to 0.05; Cappelli et al., 1997;
MacRae et al., 1997b; Yu et al., 2000). These data are in agreement with the present
results employing isolated luminal cells for incubations and where leucine was not
found to be metabolized via the Krebs cycle.
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Most of what is known about EAA metabolism in ruminants in vivo has been
gleaned from the use of [13C] or [14C]leucine tracers, mainly on the grounds of cost.
Whilst the metabolism of leucine may give some clues to the general metabolism of
other EAA, this assumption is probably incorrect and requires validation. Herein,
valine was found to be metabolized to KIV by REC and at a higher rate (31-80%)
than for DMC (20-65%). As was the case with KIC production from leucine, KIV
derived from valine was not channeled to the Krebs cycle for complete catabolism.
Glutamate was the single most important contributor to Krebs cycle
intermediates, and its carbon accounted for 4-54% of α-ketoglutarate. Glutamate
contribution to α-ketoglutarate increased with increased supply and was higher in
REC (13-54%) than in DMC (4-25%). By contrast, glutamine’s contribution to α-
ketoglutarate flux did not exceed 3% for REC and DMC.
Previous studies in sheep have shown that glucose addition to REC and DMC
incubation media reduced CO2 production from glutamine (Harmon et al., 1986;
Okine et al., 1995; Oba et al., 2004). By contrast, the addition of glucose to DMC
incubations had no effect on reducing CO2 production from glutamate (Oba et al.,
2004). These authors suggested that DMC could have an obligate requirement for
glutamate oxidation or that the small differences noted were outwith the sensitivity of
their measurements. We had expected that glutamine would contribute substantially
to α-ketoglutarate flux in DMC, given that CO2 production (6 vs 1.8 nmoles) from
glutamine exceeded those from glutamate at similar concentrations (Oba et al., 2004).
We can only speculate that the limited metabolism of glutamine in the Krebs cycle, as
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is observed in rats (Watford, 1994), relates to some form of compartmentation of
glutamine and glutamate catabolic pathways.
The proportion of succinate flux (3-15%) derived via α-ketoglutarate was
lower than we had anticipated, and this suggests that flux through succinate also
involves contributions from other unlabelled substrates catabolized for entry into the
cycle at succinyl-CoA. However, we did observe a large contribution of α-
ketoglutarate to malate flux (4-40%), which follows succinyl-CoA in the Krebs cycle
pathway.
In conclusion, the approach we used in this study has been used in profiling
cardiac metabolism in the working heart muscle (Des Rosier et al., 1994), and to our
knowledge this is the first attempt to provide a more complete profile of major
substrates metabolized by cells lining the lumen of the ruminant GIT. These data
provide evidence that glutamate is the single most important (9-41%) substrate
contributing to the Krebs cycle intermediates, a process referred to as anaplerosis
because of the importance of this process in ensuring replenishment of intermediates
that leave the Krebs cycle via cataplerosis. By contrast, glutamine’s contribution to
Krebs cycle flux via α-ketoglutarate did not exceed 3% of its flux. Despite the large
contribution of glucose to lactate flux (8-31%), there was no detectable entry of
glucose carbon skeletons into the Krebs cycle. We believe that this process serves a
role in preserving glucose carbon skeletons, in particular 3-carbon skeletons, from




Ingredients and nutrient composition of the experimental diets1
High forage High concentrate
Ingredient g/kg dry matter
Orchardgrass, silage 750 250
Ground corn 167 554
Soybean meal 59 172
Calcium carbonate 12 14
Dicalcium phosphate 2 -
Vitamin mix 5 5
Mineral mix 5 5
Nutrient composition (calculated)
Dry matter 305 680
Crude protein 137 174
Acid detergent fiber 332 140
Neutral detergent fiber 553 245
Crude fat 38 38
Metabolizable energy, MJ/kg 8.8 11.7
1 Mineral mix provided per kg premix: calcium, 220 g; salt 160 g; sulfur, 31 g;
phosphorus, 30 g; magnesium, 27 g; potassium, 24 g; iron 1,820 mg; zinc 2,700 mg;
manganese 240 mg ; iodine 40 mg; cobalt 35 mg ; selenium 24 mg.
Vitamin mix provided per kg premix: vitamin A, 682,799 IU; vitamin D, 137,574 IU;
vitamin E, 1,774 IU.
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TABLE 4.2
Composition of media used in primary cell incubations
Calculated concentration






























Concentration of [13C]tracers used in primary cell incubations
Tracer substrates Calculated concentration
Level 1 2 3 4
Duodenal Mucosa1 mmol/L
[13C6]Glucose 1.000 2.000 4.000 10.000
[13C2]Acetate 0.220 0.440 0.880 2.190
[13C3]Propionate 0.010 0.020 0.040 0.090
[1-13C1]Butyrate 0.002 0.004 0.009 0.021
[13C6]Leucine 0.060 0.120 0.230 0.580
[13C5]Valine 0.080 0.160 0.330 0.810
[13C5]Glutamine 0.040 0.070 0.150 0.360
[13C5]Glutamate 0.070 0.130 0.270 0.660
Rumen epithelia2
[13C6]Glucose 1.000 2.000 4.000 10.000
[13C2]Acetate 16.000 32.000 64.000 160.000
[13C3]Propionate 6.000 12.000 23.000 58.000
[1-13C1]Butyrate 4.000 8.000 15.000 38.000
[13C6]Leucine 0.060 0.120 0.230 0.580
[13C5]Valine 0.080 0.160 0.330 0.810
[13C5]Glutamine 0.040 0.070 0.150 0.360
[13C5]Glutamate 0.070 0.130 0.270 0.660
1 Incubation media with [13C6]glucose [
13C6]acetate [
13C6]propionate and
[13C6]butyrate contained 25 moles [
13C6]tracer per 100 moles unlabelled tracee.
2 Incubation media with [13C6]glucose contained 25 moles [




Fractional contribution of glucose to pyruvate flux (FCGlucose→ Pyruvate) in
rumen epithelial (REC) and duodenal mucosal cells (MDC) isolated from bulls fed




(mmol/L) FCGlucose→ Pyruvate, %
HC REC 1 1.3
HC REC 2 1.7
HC REC 4 1.9
HC REC 10 2.4
HC DMC 1 2.2
HC DMC 2 2.5
HC DMC 4 3.4
HC DMC 10 7.3
HF REC 1 0.4
HF REC 2 0.9
HF REC 4 0.9
HF REC 10 1.1
HF DMC 1 2.5
HF DMC 2 3.7
HF DMC 4 4.8






Diet × level NS
Diet × tissue NS
Tissue × level 0.0213
Diet × tissue × level NS
1 The incubation contained 25 moles [13C6]glucose per 100 moles unlabelled glucose.
Therefore, the contribution of glucose to lactate flux was calculated as pyruvate
[M+3]/25 molar % [13C6]glucose.
2 NS= not significant (P>0.05); SEM= pooled standard error of the means.
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Table 4.5
Fractional contribution of glucose to lactate flux (FCGlucose→ Lactate) in rumen
epithelial (REC) and duodenal mucosal cells (MDC) isolated from bulls fed high





HC REC 1 22.0
HC REC 2 25.7
HC REC 4 26.3
HC REC 10 30.9
HC DMC 1 22.0
HC DMC 2 25.0
HC DMC 4 27.6
HC DMC 10 29.7
HF REC 1 8.1
HF REC 2 11.0
HF REC 4 12.9
HF REC 10 15.4
HF DMC 1 21.0
HF DMC 2 25.2
HF DMC 4 27.1






Diet × level NS
Diet × tissue 0.0001
Tissue × level NS
Diet × tissue × level NS
1 The incubation contained 25 moles [13C6]glucose per 100 moles unlabelled glucose.
Therefore, the contribution of glucose to lactate flux was calculated as lactate
[M+3]/25 molar % [13C6]glucose.
2 NS= not significant (P>0.05); SEM= pooled standard error of the means.
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Table 4.6
Fractional contribution of leucine to [M+6]ketoisocaproic acid (FCleucine→
ketoisocaproic) in rumen epithelial (REC) and duodenal mucosal cells (MDC)
isolated from bulls fed high concentrate (HC) or high forage (HF) diets, and




HC REC 0.06 19.8
HC REC 0.12 34.7
HC REC 0.24 55.4
HC REC 0.60 68.0
HC DMC 0.06 15.5
HC DMC 0.12 25.8
HC DMC 0.24 38.8
HC DMC 0.60 59.7
HF REC 0.06 15.7
HF REC 0.12 25.1
HF REC 0.24 38.2
HF REC 0.60 57.9
HF DMC 0.06 19.3
HF DMC 0.12 28.2
HF DMC 0.24 41.0






Diet × level NS
Diet × tissue 0.0068
Tissue × level NS
Diet × tissue × level NS
1 NS= not significant (P>0.05); SEM= pooled standard error of the means.
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Table 4.7
Fractional contribution of valine to [M+5]ketoisovaleric acid (FCvaline→
ketoisovaleric) in rumen epithelial (REC) and duodenal mucosal cells (MDC) isolated





HC REC 0.08 38.5
HC REC 0.16 55.7
HC REC 0.33 71.7
HC REC 0.81 85.8
HC DMC 0.08 24.4
HC DMC 0.16 37.0
HC DMC 0.33 55.3
HC DMC 0.81 74.1
HF REC 0.08 26.5
HF REC 0.16 43.9
HF REC 0.33 61.0
HF REC 0.81 78.0
HF DMC 0.08 13.8
HF DMC 0.16 27.0
HF DMC 0.33 36.6






Diet × level NS
Diet × tissue NS
Tissue × level NS
Diet × tissue × level NS
1 NS= not significant (P>0.05); SEM= pooled standard error of the means.
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Table 4.8
Fractional contribution of glutamate to [M+5] α-ketoglutarate (FCGlutamate→ α-
ketoglutarate) in rumen epithelial (REC) and duodenal mucosal cells (MDC) isolated





HC REC 0.07 15.6
HC REC 0.13 28.0
HC REC 0.27 41.2
HC REC 0.66 62.5
HC DMC 0.07 2.8
HC DMC 0.13 5.9
HC DMC 0.27 8.9
HC DMC 0.66 17.9
HF REC 0.07 10.3
HF REC 0.13 17.2
HF REC 0.27 26.8
HF REC 0.66 46.2
HF DMC 0.07 4.3
HF DMC 0.13 7.6
HF DMC 0.27 16.8






Diet × level NS
Diet × tissue 0.0001
Tissue × level 0.0001
Diet × tissue × level 0.0074
1 NS= not significant (P>0.05); SEM= pooled standard error of the means.
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Table 4.9
Fractional contribution of glutamine to [M+5] α-ketoglutarate (FCGlutamine→ α-
ketoglutarate) in rumen epithelial (REC) and duodenal mucosal cells (MDC) isolated





HC REC 0.04 0.5
HC REC 0.07 0.7
HC REC 0.15 1.2
HC REC 0.36 2.3
HC DMC 0.04 0.1
HC DMC 0.07 0.8
HC DMC 0.15 1.5
HC DMC 0.36 2.7
HF REC 0.04 0.2
HF REC 0.07 0.4
HF REC 0.15 0.7
HF REC 0.36 1.6
HF DMC 0.04 0.3
HF DMC 0.07 0.6
HF DMC 0.15 1.2






Diet × level NS
Diet × tissue NS
Tissue × level NS
Diet × tissue × level NS
1 NS= not significant (P>0.05); SEM= pooled standard error of the means.
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Table 4.10
Fractional contribution of α-ketoglutarate to succinate (FC α-KG→Suc), α-
ketoglutarate to malate (FC α-KG→Mal), malate to oxaloacetate (FC Mal →Oaa) in
rumen epithelial (REC) and duodenal mucosal cells (MDC) isolated from bulls fed




FCα-KG→Suc FC α-KG→Mal FC Mal→Oaa
HC REC 0.07 2.6 6.3 22.2
HC REC 0.13 2.6 5.4 24.7
HC REC 0.27 3.1 4.6 26.7
HC REC 0.66 4.1 4.3 32.1
HC DMC 0.07 7.7 42.0 43.7
HC DMC 0.13 7.8 37.8 67.4
HC DMC 0.27 5.9 37.1 79.6
HC DMC 0.66 4.6 30.5 79.7
HF REC 0.07 6.0 15.7 28.5
HF REC 0.13 6.3 15.4 31.4
HF REC 0.27 6.5 11.9 37.2
HF REC 0.66 7.1 10.3 41.6
HF DMC 0.07 15.0 39.5 59.5
HF DMC 0.13 15.4 35.0 57.9
HF DMC 0.27 13.7 28.2 61.3
HF DMC 0.66 12.8 24.0 63.6
SEM 4.099 4.742 9.210
Effect P-value
Diet NS NS NS
level NS 0.0025 NS
Tissue 0.0001 0.0001 0.0001
Diet × level NS NS NS
Diet × tissue NS 0.0001 NS
Tissue × level NS NS NS
Diet × tissue × level NS NS NS
1 NS= not significant (P>0.05); SEM= pooled standard error of the means.
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Figure 4.1. Mass isotopomer distribution of pyruvate from rumen epithelial (REC)
and duodenal mucosal (DMC) cells isolated from bulls fed high forage (HF) or high







denotes values that are significantly different from 0 (P<0.05). abc values not sharing a
common letter differ significantly (P<0.05).
















































Figure 4.2. Mass isotopomer distribution of lactate from rumen epithelial (REC) and
duodenal mucosal (DMC) cells isolated from bulls fed high forage (HF) or high







denotes values that are significantly different from 0 (P<0.05). abc values not sharing a
common letter differ significantly (P<0.05).











































Figure 4.3. Mass isotopomer distribution of α-ketoglutarate from rumen epithelial
(REC) and duodenal mucosal (DMC) cells isolated from bulls fed high forage (HF) or







denotes values that are significantly different from 0 (P<0.05). abc values not sharing a
common letter differ significantly (P<0.05).









































































Figure 4.4. Mass isotopomer distribution of oxaloacetate from rumen epithelial (REC)
and duodenal mucosal (DMC) cells isolated from bulls fed high forage (HF) or high







denotes values that are significantly different from 0 (P<0.05). abc values not sharing a
common letter differ significantly (P<0.05).



































































Figure 4.5. Fractional contribution of glutamate to α-ketoglutarate, succinate, malate,
and oxaloacetate from rumen epithelial (REC) and duodenal mucosal (DMC) cells
isolated from bulls fed high forage (HF) or high concentrate (HC) diet and incubated
with [13C5] glutamate.
abc values not sharing a common letter differ significantly
(P<0.05).


























































































































































The gastrointestinal tract (GIT) plays a significant role in determining the
efficiency by which amino acids (AAs) and energy are deposited in productive
tissues. The GIT not only dictates nutrient delivery to productive tissues from luminal
supplies, but also competes with these tissues for nutrients from blood supplies. The
high metabolic demand for AAs by the GIT relates to protein synthesis and energy
production. One area susceptible to manipulation is AA utilization for energy
production, and decreasing it might provide a means to enhancing the efficiency of
AA utilization in productive tissues.
The overall hypothesis of this dissertation research was that the GIT of
ruminant animals catabolizes AA preferentially. We sought to determine whether this
catabolism represents an obligate requirement, and whether this requirement stems
from the need to generate energy or support other metabolic demands.
Glucose metabolism by the GIT was investigated in sheep fed a low protein
diet and given duodenal infusions of glucose or glucose/casein. Small intestinal
protein supplies increased (18 vs 35%) the contribution of luminal (first-pass) and
decreased (82 vs 65%) that of arterial glucose utilization by the GIT. Despite this
shift, total glucose utilization remained unchanged and the GIT utilized 48-51% of
glucose available from absorption and gluconeogenesis, mainly glucose derived from
the arterial circulation. We had hypothesized that if AAs, and not glucose, are the
preferential energy substrates of the GIT, then intestinal infusion of casein would lead
to a reduction in glucose use by the GIT. Our results indicated that total GIT use of
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glucose was not affected by additional luminal AA supply, and therefore under these
conditions, glucose metabolism by the GIT was obligatory.
The second study aimed at establishing the extent by which AAs are net
metabolized by the GIT of growing sheep, and at determining the extent by which
AAs are used from arterial and luminal supplies in response to increased protein
supply to the small intestine. The efficiency of absorption across the GIT of all the
essential AAs, except the BCAAs, was 100% and this remained fixed at all levels of
protein supply, whereas the efficiency of absorption of BCAAs was 60-66%. By
contrast, the high removal rates of glutamate, glutamine, and serine remained constant
even at the upper levels of protein supply. The ruminant GIT appears to metabolize
increasing amounts of the BCAAs and certain non-essential AAs when the intestinal
supply of protein is increased. The basis for this disproportionate metabolism of some
AAs with increased intestinal protein supply could suggest their utilization for energy
production.
The flux and contribution of glucose, AAs, and SCFAs to overall Krebs cycle
metabolism was determined in rumen epithelial (REC) and duodenal mucosal (DMC)
cells of beef cattle. Our results indicated that despite the high flux of glucose to
lactate (8-31%), leucine to ketoisocaproic acid (17-63%), and valine to ketoisovaleric
(19-82%), there was no detectable entry of glucose leucine and valine to Krebs cycle
intermediates. In contrast, glutamate contributed 9-41% of α-ketoglutarate flux, while
glutamine contribution did not exceed 3%. Our hypothesis was that REC and DMC
are metabolically flexible in substrate selection for catabolism in the Krebs cycle, and
that this metabolism is affected by diet and substrate availability. The results of this
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study suggest that only glucose metabolism by REC is affected by dietary
manipulations. Moreover, the supplies of glutamate and glutamine increased their
contribution to Krebs cycle intermediates, and as a result decreased the contribution
of other substrates entering the cycle.
The results of these studies underline the extent by which the GIT metabolizes
macronutrients. In this respect, the GIT seems to have an obligate requirement for
macronutrients. The basis for this catabolism remains uncertain for certain substrates.
Firstly, glucose utilization from arterial and luminal supplies represents a large
proportion of glucose available form absorption and gluconeogenesis and the large
removal of glucose by GIT cells occurs towards lactate production and possibly
alanine. Glucose catabolism to lactate and alanine may serve as a mechanism to
conserve 3 carbon units from catabolism, while maintaining the supply of glycolytic
intermediates to support other metabolic demands. In this regard, additional research
is needed to determine the significance of glucose partial catabolism to 3 carbon
intermediates by the GIT.
Secondly, although previous studies have reported branched chain AA
(BCAA) oxidation to CO2, our results indicated that they do not enter Krebs cycle
intermediates. Hence, their catabolism may represent microbial degradation in the
lumen of the GIT. However, our results raise a new question about the significance of
the large amounts of BCAAs removed by the GIT and the fate of their amino-
nitrogen.
Thirdly, the large removal of glutamate and glutamine by the GIT would
imply that the requirements for these AAs in the liver and peripheral tissues must be
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met through de novo synthesis, possibly from essential AAs and glucose. While
glutamate catabolism occurs primarily via α-ketoglutarate, which subsequently enters
the Krebs cycle, the fate of glutamine remains unclear. These observations suggest
that increasing the supplies of glutamate would decrease the contribution of other
substrates entering Krebs cycle intermediates at or beyond α-ketoglutarate. Our
results also suggest that the requirement for glutamine may occur to meet other
metabolic demands. In this respect investigating the catabolic pathway(s) of





Three assumptions are needed for tracer studies:
1. The system cannot differentiate between tracer and tracee.
2. Steady state conditions.
3. Tracer and tracee share the same entry sites to body pools.
When a tracer is infused into a pool, it is considered that after a time t, the
pool will be in isotopic equilibrium with the input and the rate of disappearance.
outpoolin EEE == (1)
Where inE is the enrichment of the tracee entering the pool, poolE the enrichment in
the pool and outE the enrichment in the tracee exiting the pool. The enrichment is
calculated as mole tracer per mole of tracee.
inin tracee)mol/tracermol(E = (2)
poolpool tracee)mol/tracermol(E = (3)
Substituting equations (2) and (3) in equations (1) gives equation (4):
poolin Etracee)mol/tracermol( = (4)
Because the tracer and tracee enter the pool simultaneously, then if we divide the
numerator and the denominator on one side of the equation by the time t, equation
(4):
PoolRate of appearance of tracee (Ra)
Rate of appearance of tracer (Ra*) 
Rate of disappearance (Rd)
Rate of disappearance (Rd*)
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poolin Et)tracee/mol)/(ttracer/mol( = (5)
Where, t)tracer/mol( is the isotope infusion rate (IR ) in mol/ min, and
t)tracee/mol( is the rate of appearance (Ra ) of the tracee in the pool. Equation (5)
can be written as:
poola ER/IR = (6)
Rearrange (6),
E/IRR poola = (7)
The tracer is not 100% enriched, at a given label position, so a correction is needed
that takes into account this incomplete labeling:
tracertrue EIRIR ×= (8)
Where trueIR is the true infusion rate of the tracer (mol/ min), Substituting equation
(8) in equation (7) gives:
E/EIRR pooltracera ×= (9)
If we consider a case where no tracee is added to the pool then the enrichment of the
infused solution and the enrichment of the pool will be equal and Ra will be equal to
the rate of infusion of the tracer.
This is why another correction is required in equation (9) to account for the tracer
infused into the pool by an amount equal to the infusion rate IR (mol/ min)
IR-)E/EIR(R pooltracera ×= (10)
Rearranging (10) gives,
1)IR-)E/E((R pooltracera = (11)
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Arterial and duodenal removal
Net flux (absorption or removal) of tracer is calculated from plasma flow and arterio-
venous concentration difference. The amount of tracer supplying and leaving the
tissue is calculated from the concentration and enrichment of the tracee.
PFA]A[inTracer E ××= (8)
PFV]V[outTracer E ××= (9)
Where ]A[ and ]V[ are the arterial and venous concentrations, AE and VE are the
arterial and venous enrichments, and PF is the plasma flow. The net rate at which the














Replacing equations (8) and (9) in (10) gives:
PFV[V]-PFA[A]fluxNet EE ××××= (11)
Taking PF as a common factor;
PF)V[V]-A([A]fluxNet EE ×××= (12)
The fractional use of the arterial tracer is the tracer net flux calculated as a proportion









Arterial use of the tracee is calculated from the arterial supply of the tracer (tracee in)
multiplied by the fractional use of the arterial tracer (13);
fuaPF[A]nutilizatioArterial ××= (14)
Luminal (i.e. first-pass) use of the tracer is calculated from the recovery of duodenal
tracer. Given that some recycling (appearance in arterial blood) of the luminal tracer
will occur, luminal use will be overestimated by an amount equal to the tracer
removed from arterial circulation.
(([V] × EV) − ([A] × EA) + ([A] × EA × fua × PF))/IRd (15)
Where ]A[ and ]V[ are the arterial and venous concentrations, AE and VE are the
arterial and venous enrichments, PF is the plasma flow, fua is the fractional arterial
utilization and IRd is the luminal tracer infusion rate.
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Molecular Formula = C16H21NO10
Formula Weight = 387.33864
Glucose-aldonitrile pentaacetate
Molecular Formula = C16H21NO10






















Fragmentation of proline, threonine, histidine and valine t-butyldimethylsilyl
(TBDMS) derivatives under electric ionization
Molecular Formula = C17H37NO2Si2
Formula Weight = 343.65218
Proline TBDMS derivative
Molecular Formula = C22H51NO3Si3































































Molecular Formula = C24H51N3O2Si3
Formula Weight = 497.93714
Histidine TBDMS derivative
Molecular Formula = C17H39NO2Si2

























Fragmentation of Serine, methionine, lysine and phenylalanine t-butyldimethylsilyl
(TBDMS) derivatives under electric ionization
Serine TBDMS derivative
Molecular Formula = C21H49NO3Si3































Molecular Formula = C24H56N2O2Si3
Formula Weight = 488.97014
Lysine TBDMS derivative
Molecular Formula = C17H39NO2SSi2




















Molecular Formula = C21H39NO2Si2












































Fragmentation of aspartate, glutamate, tyrosine and glutamine t-butyldimethylsilyl

























Molecular Formula = C22H49NO4Si3
Formula Weight = 475.88526
Aspartate TBDMS derivative
Molecular Formula = C23H51NO4Si3
Formula Weight = 489.91184
Glutamate TBDMS derivative
Molecular Formula = C27H53NO3Si3
Formula Weight = 523.97112
Tyrosine TBDMS derivative
Molecular Formula = C23H52N2O3Si3




















































































Fragmentation of urea t-butyldimethylsilyl (TBDMS) derivatives under electric
ionization
Urea TBDMS derivative
Formula Weight = 288.57698



















Fragmentation of α-ketoglutarate-oxime, pyruvate-oxime, lactate and oxaloacetate t-
butyldimethylsilyl (TBDMS) derivatives under electric ionization
Molecular Formula = C23H49NO5Si3
Formula Weight = 503.89536
α-Ketoglutarate-oxime TBDMS derivative
Molecular Formula = C15H33NO3Si2
Formula Weight = 331.59842
Pyruvate-oxime TBDMS derivative
Molecular Formula = C15H34O3Si2
Formula Weight = 318.59966
Lactate TBDMS derivative
Molecular Formula = C22H47NO5Si3

























































































Fragmentation of succinate, malate, ketoisocaproic-oxime (KIC), and ketoisovaleric-
oxime (KIV) t-butyldimethylsilyl (TBDMS) derivatives under electric ionization.
Molecular Formula = C16H34O4Si2
Formula Weight = 346.60976
Succinate TBDMS derivative
Molecular Formula = C22H48O5Si3














































Molecular Formula = C18H39NO3Si2
Formula Weight = 373.67816
KIC-oxime TBDMS derivative
Molecular Formula = C17H37NO3Si2











































Fragmentation of succinate β-hydroxybutyrate t-butyldimethylsilyl (TBDMS)
derivatives under electric ionization
Molecular Formula = C16H36O3Si2























Schematic representing 13C-labeling in glycolysis and Krebs cycle intermediates at


















































































































































Schematic representing 13C-labeling in glycolysis and Krebs cycle intermediates at
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